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III. Abstract  
Title: Intensive Paediatric Case Finding (IPCF); evaluation of a PASADA programme for 
identification of HIV positive children and adolescents in Dar es Salaam, Tanzania.   
 
Background: An estimated 390 000 worldwide new paediatric HIV infections occurred in 2010 
alone.  If these children do not have access to antiretroviral therapy, less than 25% of them 
would survive past the age of five years. Identification of HIV infected children is essential to 
provide comprehensive HIV care and treatment; however, only an estimated 15% of HIV 
exposed infants globally receive HIV testing in the first two months of life thus strategies to 
increase identification of HIV infected children are critically needed. PASADA, a non-profit 
organization based in Dar es Salaam, Tanzania, developed a programme to identify HIV infected 
children and adolescents named Intensified Paediatric Case Finding (IPCF) which utilized the 
existing community networks which include: health care providers, hospital visitors, friends, 
families and patients of the PASADA medical centre. The purpose of the study was to evaluate 
the impact of the IPCF in improving identification of HIV positive children. Contrary to other two 
traditional approaches for HIV testing, Voluntary Counselling and Testing (VCT) and Provider 
Initiated Counselling and Testing (PICT), the IPCF approach initiates the process of HIV testing 
for children by identifying children while at the community through utilization of community 
social networks whereas, VCT and PICT interventions initiate the process of HIV testing for 
children who have already presented at health facilities for either an HIV test or other health 
needs. Also IPCF uses unspoken social clues to identify children who are at higher risk of being 
exposed to HIV and it widens the scope of people who influence the process of HIV test in 
children without violating a legal obligation of primary caregivers to provide consent for an HIV 
test for children. Specific AIMS:  (1) to determine the impact of IPCF intervention in 
identification of HIV positive children, (2) to determine perceptions of guardians on the IPCF 
and VCT approaches, (3) to assess experience of living with HIV among children living with HIV 
and their guardians, and (4) to compare characteristics of HIV positive children identified 
through IPCF and VCT approaches. 
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Material and methods: A prospective, cross-sectional descriptive study was conducted 
between January and April, 2011 and a total of 227 participants were recruited from PASADA 
clinics (IPCF=151 and VCT=76). The average age for children in the IPCF and VCT groups were 
11.3(SD=3.5) and 12.6(SD 3.5) years respectively.  We administered structured questionnaire in 
addition to a retrospective review of PASADA health records before and after IPCF began. Both 
Qualitative [focus group discussion] and quantitative [questionnaires] methods were used to 
collect the information. Results: There was  no significant difference in CD4 count at the initial 
visit between IPCF and VCT clients, however over 33% of participants in each groups had CD4 < 
200 cells per microliter. New enrolment increased at the beginning of the IPCF programme in 
January 2010 and showed sustained increases through July 2010 by 42% (p=0.001). The study 
revealed that participants in the IPCF group were significantly more likely to have visited more 
providers prior to being diagnosed with HIV than VCT participants (46% vs. 31%, respectively; 
p=0.001).  Conclusion:  IPCF provides a model for leveraging existing community structures to 
identify HIV-infected children who have previously been undiagnosed in the formal health 
sector. This model could be expanded in other settings to increase HIV testing and strengthen 
linkages to care for children. Efforts to expand IPCF to identify more children, especially those 
at earlier stages of disease progression, should be developed. 
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CHAPTER ONE: Introduction and Literature review.  
1.1.1. Background  
A high prevalence of HIV in children has slowed down the progress to reduce child mortality in 
Sub Saharan Africa countries (Kellerman & Essajee, 2010). Global reports have shown that 
children account for 18% of HIV-related deaths and 15% of new HIV infections each year in 
Africa (Blasini et al, 2004:181). In 2007, UNAIDS estimated that approximately 6.2% of 33.4 
million people living with HIV globally were children and over 90% of these infections in 
children were attributed to vertical transmission of HIV (UNAIDS, 2008a:37). Worldwide reports 
on the burden of HIV estimated AIDS to be the eighth leading cause of death among 
adolescents aged 15 to 19 years and the sixth leading cause of death among adolescents aged 
10 to 14. However, in countries with high HIV prevalence, AIDS ranked much higher in the list of 
causes of death among adolescents (UNICEF, 2011:24). In Africa, the proportion of new HIV 
infections in children has remained high. In 2008 alone, of the estimated 2.7 million new HIV 
infections, 430 000 (16%) infections were in children. In 2009, two million of world-wide deaths 
were attributed to HIV and AIDS and 280 000 (14%) death occurred in children. In Sub Saharan 
Africa, HIV has caused more deaths than any other infectious diseases, having overtaken 
malaria and tuberculosis as cause of death (Matlin & Nancy, 2000).  Lack of equality in laws of 
inheritance in Tanzania is a huge challenge and has particularly left women and children 
suffering especially in the light of AIDS pandemic (Tamar, 2011: 602-662).   
 
Despite the tragedy depicted by these numbers, the current efforts have not provided much 
impact on the problem of HIV in children thus more needs to be done (Foster, 1997:82). 
Progress toward achieving the millennium development goal four (reduce child mortality) in 
many countries from Sub Sahara African has not promised to align with the expectations 
(Global Health Workforce Alliance, 2010), therefore review of traditional strategies to revert 
child mortality is critically needed. 
 
 
12 
 
 
Tanzania, East Africa has a population of 44, 928, 923 people with a 2.7% population growth 
rate. The country constitutes 25 regions, 20 being in the mainland and 5 in Zanzibar (National 
Bureau of Statistics, 2012). The prevalence of HIV in adults aged 15-49 years has been reported 
to decline from 6 percent to 5 percent between 2007 and 2012 (TACAIDS, 2013:109-111). 
Tanzania is among the countries worldwide hardest hit by HIV with high prevalence of HIV in 
children. According to the 
United Nations (UN) report, Tanzania has 
reported a continuous increase in the 
number of children living with HIV from 
38,000 people in 1990 to 230,000 in 2011 
(Mundi Index, 2013). This is already a very 
high pace compared to many other countries 
worldwide. The government of Tanzania has 
strived improve access to HIV testing services 
for the citizens through various targeted 
interventions in collaboration with the 
private and donor communities. In 2007, the president of Tanzania his excellence Dr. Jakaya 
Mrisho Kikwete launched a national HIV testing campaign as a strategy to roll-out HIV testing 
services in urban and rural areas (TACAIDS, 2007).  
 
1.1.2 Counselling and testing 
HIV voluntary counselling and testing (VCT) is a process by which an individual undergoes 
confidential counselling to learn about his/her HIV status and to exercise an informed choice in 
testing for HIV. The client must make the decision to pursue counselling and testing on his/her 
own free will on the basis of the information provided during the counselling session, i.e. an 
informed decision. The client also has the option to terminate or postpone participation at any 
point in the process (NACP, 2005a:102). Provider Initiated Counselling and Testing (PICT) is a 
confidential dialogue between a person attending a healthcare facility and a health care 
Map of Dar es Salaam: Geographical location of the study area 
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practitioner aimed at enabling that person to make an informed personal decision about HIV 
testing in order to access treatment, care and support services. This process encompasses pre-
test information and post-test counselling (NACP, 2007:3). Both the VCT and PICT approaches 
pick children after when they show up in the facility.  
1.1.3 PMTCT coverage 
There are examples of effective Prevention of Mother to Child HIV Transmission (PMTCT) 
programme to prevent vertical transmission of the infection and in theory it should be possible 
to eliminate childhood HIV. High incidences of HIV have been associated with low coverage of 
PMTCT programme (Tammy et al, 2007: 474). In particular, many countries in Sub Saharan 
Africa have reported low coverage of PMTCT. As a result, over 40% of new HIV infections in the 
region are due to vertical transmission of HIV (Leyenaar, 2005:259).  In contrast, higher 
coverage PMTCT programme have reported a significant reduction of maternal to child 
transmission of HIV to as low as 1% (Elijah & Warren, 2009:94). As described above PMTCT for 
HIV-positive pregnant women has remained low in many countries that have high prevalence of 
HIV. UNICEF reported poor coverage of PMTCT in Nigeria [3%] and Tanzania [15%], and 
moderate coverage in South Africa [50%] (UNICEF, 2008). In contrast, many of countries in the 
European and America regions with low prevalence of HIV have reported higher coverage of 
PMTCT programme for women who attend antenatal clinics. In 2010, Ukraine and Brazil both 
reported 90% coverage of PMTCT programmes (Low-Beer & Sarkar, 2010:12). A low coverage of 
PMTCT services has resulted in many children being born to HIV infected mothers who never 
tested for HIV and never received PMTCT prophylaxis. Kellerman & Essajee (2010) have 
reported that it is unlikely that these children will be identified unless there is a targeted testing 
strategy. 
 
1.1.4 Care and treatment services for HIV positive children 
In recent years, progress has been made globally to expand access to antiretroviral therapy 
(ART) for both adults and children. Despite a dramatic increase in a number of HIV-positive 
children who received care and treatment services between 2005 and 2008, the number 
represent a small proportion of children who needed the services (Kellerman & Essajee, 2010).  
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Counselling and Testing for HIV is a critical initial step before ART is initiated. The 2010 United 
Nations (UN) report on HIV and AIDS epidemiology revealed that paediatric HIV counselling and 
testing services lag behind and are less developed as compared to HIV counselling and testing 
services for adults (UNAIDS, 2010:79-82). For example, in 2009, it was estimated that 1 276 000 
children aged 15 years and below were eligible for ART; of this number only 356 400 (28%) 
were initiated on treatment (UNICEF, 2010:11-15). The question why there are so few children 
in ART has been asked for decades and Kellerman & Essajee (2010) in their report proposed a 
primary reason to be insufficient systems for identification and linkage of HIV infected children. 
A study done by Laufer, Van & Joep (2006:623) in Lesotho had similar findings indicating that 
children are largely underrepresented among those accessing treatment for HIV infection in 
Africa.  Initiation of antiretroviral treatment to HIV positive children is a sole and powerful way 
of reversing escalating trends of child mortality due to HIV in many Sub Saharan African 
countries. Initiation of ART has a very significant impact on health outcomes. Data from the 
South African CHER study reported a 75% child mortality reduction immediately after initiation 
of antiretroviral treatments to children who were vertically infected with HIV (Violari et al, 
2008:2233). A study conducted in Tanzania by Mmbando, Hartwig, Hofgren et al (2010:4) on 
social predictors of health outcomes among orphaned children described a number of major 
social determinants of health for infants and children with one or more parents dying or dead 
from HIV. These include pervasive poverty, weak community social support systems, lack of 
policy commitment by governments or foreign donors, lack of access to anti-retroviral drugs, 
limited access to schools, and gender limitations. Also a study conducted by Nöstlinger, Bartoli, 
& Gordillo (2006:29) reported that living with HIV positive children has been associated with 
challenges that interfere with provision of social support by guardians and some of the 
challenges include: lack of knowledge on how to care for children with HIV associated 
infections, poverty and stigma. 
 
1.1.5 HIV testing in children  
Evidence on missed opportunities to diagnose HIV infection in children and adolescents within 
the health systems have been reported (WHO, 2010:1). According to the World Health 
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Organization (WHO) report of 2009, only 8% of HIV-exposed infants received early virological 
testing in 2008 (WHO, 2009: 21-22). Analysis of international cohort data has confirmed that 
very few HIV-infected children are started on antiretroviral therapy; and those children who 
receive ART are started on treatment when they are already very sick, largely due to a delay in 
HIV testing (Sutcliffe et al., 2008:877). High prevalence of utilizing traditional healers in African 
countries has rendered effort to combat HIV/AIDS in the region. Is estimated that 80 percent of 
people in African countries consult with traditional healers before or during consulting with 
biomedical practitioners (Unite for Site, 2013) the practice that authors has been attributed to a 
delayed diagnosis of HIV in children (Allen, 2007:359). A study conducted in Zimbabwe to assess 
the effectiveness of PICT detection of children showed children are identified at a very late 
stage of HIV disease progression (Topp et al., 2012: 1735). Expanded access to HIV testing and 
counselling for children is reported by authors to have numerous benefits such as: (I) early 
identification of HIV-infected infants and children as a first step to treatment and care; (II) 
identification of HIV-exposed but uninfected infants, which facilitates follow-up care and 
prevention measures that help to ensure that they remain uninfected and healthy; (III) life-
planning for parents and/or children who are HIV infected; and (IV) increased access to care 
and treatment services for children (WHO, 2007:14-17). Delayed tests for HIV have been 
reported to be associated with unwanted health outcomes such as poor adherence, increased 
frequency of opportunistic infections and death (Wortley et al., 1995:487). Cooke et al (2009:9) 
reported that timely access to care and treatment for HIV-infected infants and young children 
in South Africa remained an important challenge. Also a study conducted by Laufer, Van & Joep 
(2006:623) highlighted the need for examining different approaches to increase access to care 
and treatment services in children. Kellerman & Essajee (2010) also identified that HIV testing 
systems designed for adults do not meet the children’s needs and it is a critical time for 
programmes to increase chances for children to access HIV testing services. The WHO report on 
a scale up of diagnosis of HIV in children underlined the fact that many HIV-positive children 
have no access to HIV diagnosis and treatment (WHO, 2008:11-19). Consequently, delayed 
diagnosis of HIV in children has caused huge barriers for the scale up of ART programmes and 
hence increased the burden of HIV among children.  
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1.1.6 Guidelines for HIV testing in children 
Guidelines for antiretroviral treatment have echoed the need for early initiation of treatment 
and have suggested significant virological, immunological, and clinical benefits (Carpenter et al, 
1998:78). Many authors have named children with HIV disease “the missing face of AIDS” 
because they, more frequently than adults, lack basic health care and have been missing from 
global and national policy discussions” (UNICEF, 2005:3-5).The current national and 
international approaches for identification of HIV positive children include: Client initiated 
Voluntary Counselling and Testing [VCT] and Provider Initiated Counselling and Testing [PICT] 
(NACP, 2007:3 & WHO, 2010:7-12). A key statement in these guidelines is that “while HIV 
testing should be encouraged, it should be undertaken once the individual to be tested is both 
informed of the benefits and risks of testing and agrees to take it” (UNAIDS, 2004 & NACP, 
2007:3). Two salient dilemmas do exist in the guidelines for HIV testing in children. Firstly, the 
guidelines require health care providers to obtain consent from legal guardians if they are to 
conduct HIV tests for children below 18 years (NACP, 2007:3 & WHO, 2010:8-12). The term 
legal in this context has remains unclear for providers and guardians and has posed huge 
barriers for utilization of HIV testing services for children. Reports have shown many children 
who are HIV positive are more likely to have lost one or both of their parents due to HIV and 
those who have lost both parents have tendency to shift between different care givers 
(Leyenaar, 2005:259) without necessary legalizing the process. Urassa, Boerma & Ngalula et al. 
(2001:2017) reported a 44% household mobility of family members in Tanzania after a death of 
the head of the household due to HIV and children are the most affected members of 
respective families. Secondly, the contents of the guidelines do not offer supportive procedures 
to be followed by health care providers for involving children when HIV testing services is 
offered to them (United Nations, 2003:2). Involvement of children through understanding their 
health is one of the salient determinants of good health outcomes.  However, the need for child 
involvement varies based on their age and cognitive development and requires health care 
providers to be acquainted with these specific needs (WHO, 2011:9-13). The UN Declaration of 
Commitment on HIV/AIDS and the Convention on the Rights of the Child states that “HIV 
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testing and counselling is a fundamental to the rights and health of the children and should be 
made accessible along with the protection of their rights” (United Nations, 2003:2). Tanzania 
has endorsed the right in its National Guideline for HIV Counselling and Testing (NACP, 2007:2). 
Authors have brought attention to the benefits of exploring multiple sources of support, both 
personal (e.g. children’s friends, caregivers’ peers) and institutional (e.g. schools) for addressing 
many challenges that limit accessibility and the use-ability of medical services by HIV- positive 
children (WHO, 2011:9-15). In addition, WHO recommended a family-centred approach to HIV 
testing to ensure a maximal use of opportunities to identification of HIV-exposed and HIV-
infected children (WHO, 2010:13).   
 
1.1.7 Disclosure to children 
A study conducted by Blasini et al.  in Puerto Rico sought to assess disclosure model associated 
with healthy psychological adjustments and improved medication adherence among youth who 
are infected with HIV. In this review, the authors depicted 70% of youth had feelings of 
normality 6-months following HIV disclosure and their adherence had improved from both 
patients and caregivers. A study conducted by Bunn in Malawi supports the Puerto Rico 
findings. Bunn reports that “children knew more about their illness than they had been told, 
wanted to be told more and did better if they had had open and honest conversations about 
their illness” (Bunn, 2010:2) 
 
Lori et al. (2007: 156) conducted a systematic review of literatures aimed to explore the 
patterns on disclosing HIV diagnosis to children and identify associated controversial and 
emotionally charged issues among health care communities, caregivers, and parents. Besides 
HIV disclosure, the paper also gave an overview of disclosure of cancer in children. The key 
findings in this review include: (I), reluctance to disclosure among caregivers and parents due to 
fear of emotional consequences such as disclose of secrets of family members, (II), when 
guardians and parents started to ask health care providers to not use the words HIV and AIDS 
health care providers became concerned about ethical issues,(III), a number of health care 
providers were reluctant to accept the idea of disclosing HIV to children at an early age, and 
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there are very few guidelines for health care providers and guardians to support HIV disclosure 
process. Most of the literature sourced for the review were from a single setting relying on the 
PMTCT linkages and had small sample size.  
The analysis made by Lori et al had revealed a lack of evidence on the appropriate age for HIV 
disclosure in children, however; the authors gave a strong recommendation that HIV disclosure 
to children should be done at a school age. 
 
1.1.8 Response to HIV and AIDS in Tanzania 
A recommendation to increase coverage for PMTCT services from 12% to 80% was made by the 
government of Tanzania in order to bring maternal to child HIV transmissions to zero (HSHSP, 
2007:8). However, the burden of HIV and AIDS in children has increased continuously (Victoria 
et al, 2007:327) despite the combined public and private sector coordinated efforts to combat 
the epidemic. In response to the increasing burden of HIV in children, the government of 
Tanzania strategized that by year 2012, 20% of people living with HIV who are initiated 
antiretroviral treatment (ART) to constitute children (HSHSP, 2007:8). Of people who were 
initiated ART in years 2008 and 2009 in Tanzania, only 7% and 8% were children (NACP, 
2011:13). These findings are indicative of the urgent need for new ideas to enhance access and 
utilization of medical services for HIV-positive children in Tanzania. According to the Tanzania 
national guidelines for the clinical management of HIV and AIDS, initiation of ART in children 
age above 18 months require a confirmatory immunological test (NACP, 2005b:102), therefore 
accessibility of HIV testing services is crucial. In supporting the efforts made by the government 
of Tanzania to roll out ART services in children, Pastoral Activities and Services for People with 
HIV Dar es Salaam (PASADA) initiated a community based approach for identification of HIV 
positive children the Intensified Paediatric Case Finding (IPCF). The IPCF intervention had shown 
to increase the number of HIV-positive children who were enrolled in PASADA HIV clinics and 
those who were initiated on ART. These important findings suggested replication of the IPCF 
approach within Tanzania and other countries with high prevalence of HIV would improve 
access to ART for children eligible for the treatment; therefore evaluation of the IPCF is a critical 
initial step.   
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1.1.9 PASADA HIV care and treatment centre 
PASADA is a health and social service agency for people living with HIV and AIDS, operating 
under the umbrella of the Catholic Archdiocese of Dar es Salaam. The Organization started in 
1992 as a community-based self-support group.  PASADA added a dispensary to the existing 
services in 1994 and since then has experienced rapid professional growth in response to the 
increasing needs of people infected and by HIV and AIDS pandemic. PASADA is one of the first 
pioneer service providers in Tanzania that offers a comprehensive package of medical services  
free of charge to individuals regardless of their age, religious affiliations, sexual orientation, 
gender, and ethnic background thereby reaching all sectors of the community including the 
poorest.  PASADA serves a target population of 3.5 million people and provides a wide range of 
services along the continuum of care including: (I) Voluntary Counselling and Testing (VCT)and 
ongoing supportive counselling, (II) HIV case management, (III) Provision of Anti-retroviral drugs 
(ARV), (IV) TB diagnosis and treatment, (V) Prevention of Mother To Child HIV Transmission 
[PMTCT], (VI) Home-based palliative care, (VII) Children’s Palliative care, (VIII) Care and Support 
for Orphans and Vulnerable Children and (IX) Community Education (an HIV prevention 
programme). At the end of 2010, PASADA was providing comprehensive medical care to over 
36 046 people living with HIV (PLHIV); of this number, 13 538 PLHIV were enrolled on ART and 
of these 1 218 (9%) were children (PASADA, 2010:15). 
 
1.1.10 . Intensified Paediatric Case Finding (IPCF) 
Intensified Paediatric Case Finding is an innovative approach of active identification of HIV-
positive children. Contrary to other two traditional approaches for HIV testing, Voluntary 
Counselling and Testing (VCT) and Provider Initiated Counselling and Testing (PICT), the IPCF 
approach initiates the process of HIV testing for children by identifying children at a community 
level through utilization of community social networks whereas, VCT and PICT interventions 
initiate the process of HIV testing for children who have already presented at health facilities 
either for an HIV test or for other health issues. In addition, the IPCF approach widens the scope 
of people who may influence the initial process of an HIV test in children without violating the 
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legal obligation of primary caregivers to provide consent for an HIV test to their respective 
children. 
 
Implementation of IPCF started in October 2009 with the goal of improving treatment 
outcomes for HIV-positive children, thus improving their quality of life. The IPCF approach is an 
appropriate intervention which aligns with the WHO recommendation presented early in the 
text (WHO, 2010) calling for family-centred approaches in order to maximize opportunities for 
identification of HIV positive children and bring them to appropriate medical care.    
 
A. Objectives of the IPCF intervention 
I. To increase the percentage of HIV-positive children who were initiated on ART from 7% 
to 15% in Dar es Salaam by 2011.   
II.   To increase the percentage of HIV-positive children identified with WHO clinical stage I 
or II of HIV disease by 40% in Dar es Salaam by 2011.   
 
B. IPCF milestones 
IPCF was developed through reflection exercises conducted amongst health care providers on 
the quality of the services offered by PASADA. These reflections were done mainly between 
professionals who were performing similar or closely related duties within the PASADA systems 
of providing care. In July 2008, the medical department of PASADA institute formed a paediatric 
task force which was asked to oversee and lead an initiative to identify innovative ways of 
reducing the burden of HIV amongst children. Compelling evidence of the increased burden of 
HIV among children was evident in many of the meetings held by the paediatric task force. 
School interruptions and drop-out, recurrence of opportunistic infections that necessitated 
multiple hospital admissions, poor adherence to ART, and deaths were some of the examples of 
poor health outcomes that were identified. Most of the reported cases of poor treatment 
outcomes came from observations based on daily clinical work, that many of children with poor 
health outcomes had received HIV tests at a late stage of HIV disease progression. As a result 
the paediatric task force developed an innovative way of reducing the described burden of HIV 
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in children through utilization of the unique nature of the African Extended Family (Figure I: 
IPCF conceptual framework). The IPCF was officially launched in October 2009.  
Figure 1: IPCF conceptual framework  
 
Through a brainstorming session, the PASADA health care providers (paediatric task force) 
discussed challenges of providing care for HIV positive children. Figure one summarises the 
thinking process providers went through as they tried to identify various factors associated with 
poor health outcomes in HIV positive children. It is an unstructured depiction of the key 
elements affecting early identification of children who are HIV positive. Delayed HIV testing was 
commonly mentioned as a major factor resulting in poor health outcomes. In order to provide 
solutions for delayed HIV testing in children, the team conceptualized the thoughts and 
mapped a solution to address the challenge of delay of HIV testing in children; and IPCF 
intervention was then formulated. Figure 2 (IPCF logic model) summarizes the thinking process 
of the task force that resulted into the IPCF intervention. 
  
C. IPCF implementation plan 
The IPCF approach had three phases: (1) design, (2) awareness, and (3) strategy 
implementation.  
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Figure 2: IPCF: Logic model 
 
IPCT TASK FORCE: designed the intervention and monitored the implementation 
PASADA STAFF: Staff and selected volunteers received a train on IPCF and initiate the process 
  by asking the key IPCF questions.  
COMMUNNITY NETWORKS: These are PASADA visitors, allies, and congregations that provided  
            links between PASADA and HIV positive children in the community they lived.   
MORE CHILDREN TEST FOR HIV: More children were expected to be identified, tested and 
 linked to a care and treatment programme.   
 
D. Design and target population 
The IPCF intervention was primarily designed to benefit HIV-positive children who had yet to 
receive an HIV diagnosis. The intervention utilized the existing networks amongst and between 
health care providers, visitors, friends, families and patients of the PASADA institute. These 
groups of people were identified as “contacts” and were considered as allies whose key role 
was to link undiagnosed HIV-positive children with PASADA HIV testing centres. The 
intervention valued and utilized the existing unique nature of the African Extended Families. 
The extended family nature brought salient informational and clues that resonated with the 
overall goal of identification of HIV-positive children as early as possible and the children were 
linked to appropriate medical care. Three sets of questions were designed to instigate the 
23 
 
processes of identification of HIV-positive children. The questions were asked by health care 
providers and volunteers of PASADA and were directed to the IPCF networks within or outside 
service provision settings. Providers and volunteers were asked to assess the environment and 
willingness of the interviewee to hold a conversation that aimed at promoting health in 
children. Contrary to the PICT, the question aimed at identifying children who were still at the 
community and were likely to have no access to health services. The following set of questions 
were addressed to the contacts by PASADA staff: (1) whether they knew of children that they 
thought would benefit from an HIV test (2) if they were aware of children who had lost one or 
both of their parents and might have benefited from an HIV test. The contacts that had a “yes” 
response in either of the above questions were asked the third question; (3) whether they were 
willing to facilitate the process of linking children to PASADA clinics for appropriate medical 
check-up and subsequently care. IPCF coupons (Appendix VII) were designed to facilitate this 
referral process. Children who were identified through the IPCF approach had their clinical files 
designated with letter “C” on their initial evaluation forms. PASADA staff ensured that each 
step in the process of identification of children had retained confidentiality between healthcare 
providers and IPCF contacts. Also, procedures to disclosing HIV status for children and their 
guardians were done according to the Tanzania national guidelines for HIV counselling and 
testing.  PASADA staff who worked at different sections played a major role at the beginning 
and the end of the implementation cycle of the IPCF strategy as described in the IPCF logic 
model in figure 2.  
 
Rationale for the study 
This study is an evaluation of the IPCF strategy and aims to contribute toward better 
understanding of the root causes for persistently low number of children identified with HIV 
and subsequently initiated on ART. In this report, we describe the outcomes of IPCF 
intervention in a PASADA HIV programme and various social and clinical characteristics of HIV-
positive children and their guardians. 
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1.2 . Aim and objectives of the study 
     1.2.1. Aim  
To examine the effectiveness of the IPCF approach in identifying HIV positive children eligible 
for ART and in initiating treatment compared to the traditional VCT approach  
1.2.2.  Objectives:  
I. To determine the impact of IPCF on the number of HIV positive children identified 
before and after the intervention.  
II. To determine the perception of guardians on IPCF and VCT approaches of HIV 
identification. 
III. To assess the experience of living with HIV among children living with HIV and 
their guardians.   
IV. To compare characteristics of HIV positive children identified through IPCF and 
VCT approaches. 
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CHAPTER TWO: Methodology 
2.1. Study design: 
This is a prospective, cross-sectional descriptive study that used quantitative and qualitative 
methods for data collection and analysis. Data on the perception of children and guardians 
toward IPCF and VCT approaches, the experience of living with HIV among children living with 
HIV and guardians, and characteristics of children identified through IPCF and VCT were 
collected between January 2011 and April 2011. Data on the number of children enrolled in a 
PASADA programme seven months before and seven months after IPCF implementation were 
retrospectively gathered from a PASADA electronic database  between June 2009 to December 
2009 (before IPCF intervention), and January to July 2010 (after IPCF intervention) and the two 
groups were compared.  
 
2.2. Study site: 
IPCF study took place in Temeke, Ilala, Kinondoni and Mkuranga districts of the municipality of 
Dar es Salaam and Coast regions, in Tanzania  within PASADA clinics that include: Upendano, 
Tegeta, Mbweni, Kawe, Msimbazi, Yombo, Ukonga Vikindu, Mkuranga and Mbagala. 
  
2.3. Study population: 
HIV-positive children aged between 8 and 18 years, parents, and guardians of HIV-positive 
children who received medical care at PASADA clinics between January and April 2011. Also 
children who attended PASADA clinics and were registered in the PASADA data base between 
June 2009 and July 2010   
 
2.4. Inclusion criteria: 
For objective one: children below 18 years enrolled in a PASADA clinic between June 2009 and 
July 2010; for objective two and three: HIV positive children and their guardians attending 
PASADA clinics between January and April 2011; for objective four:  children aged 8 to 18 years 
attending PASADA clinics.  
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2.5. Exclusion criteria 
For objective two, three & four: HIV positive children below 8 and above 18 years and children 
tested negative for HIV. Children who are above 18 years are considered adults and those 
below 8 years were considered young to be involved in focus group discussions and interviews.  
For objective one all children below 18 years who tested HIV negative.  
 
2.6. Sample size 
For objectives one and four a sample size of 204 participants was derived with alpha level 5% 
and 90% power using a STATA command sampsi. 
[sampsi 32 36, alpha(.05) power(.9) sd(5.6) sd(12) ratio(2)].   
Test Ho: m1 = m2, where m1 represents  a monthly mean number of HIV-positive children 
identified before-IPCF intervention and m2 stands for a monthly mean  number of HIV-positive 
children identified after-IPCF implementation at PASADA clinics.  
Assumptions: Alpha level=   0.0500 (two-sided) 
         Power =   0.9000 
            m1 =       32, m2 =       36 
           sd1 =      5.6, sd2 =       12 
         n2/n1 =     2.00 
Estimated required sample sizes: 
         n1 =       68 
         n2 =      136 
   
In response to objectives two and three, a total of 30 focus group discussions each group with 7 
participants on average. We chose this average number of group participants for convenience 
and to ensure representation of people from both IPCF and VCT groups.      
2.7. Research team 
A team of six research assistants were recruited among PASADA staff. The team received three 
day training on use of the research protocol and ethics of conducting research in children. 
PASADA has over fifteen years of experience of working with HIV-positive children through 
provision of medical care, psychosocial, emotional, spiritual and legal support. In this regard, 
recruited research assistants had experience and skills in dealing with children. The training 
emphasised the fact that children should be recognized as vulnerable population thus ethical 
considerations were observed accordingly.    
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2.8. Data collection 
Implementation of the IPCF intervention started in January 2010 and continued through 
2011/12. Data on the impact of the intervention was collected seven months pre-intervention 
(June-December 2009) and seven months post-intervention (January-June 2010). 
  
2.8.1. Data collection tools  
Questionnaires and focus group discussion (FGD) guide were the main tools for data collection 
in response to objective 2, 3, and 4. These tools were developed initially by staff working in a 
paediatric division of the PASADA’s medical department through review of literature, clinical 
experience of researchers and consultations with the research supervisor. The tools were 
tested at three PASADA clinics other than those involved in the study and were modified 
according to the minor discrepancies denoted and re-tested to one of the PASADA clinics. In 
response to objective 1, record on patients’ attendance at PASADA clinics were obtained from 
electronic data-base. 
 
2.8.2. Data collection methods 
Both focus group discussions and interviews were conducted in Swahili language which was 
fluently spoken by research assistants, guardians, parents and children who participated in the 
study. The questionnaire captured information on demographics, detail about the child’s 
illness, and information was verified by chart review of the clinical records. A FGD guide 
(Appendix III) was used for adults and children discussions to collect information on 
participants’ experience of living with HIV and their perceptions on the approaches for HIV 
identification. 
 
2.8.3. Data collection process 
 Survey data for objective one and four. 
Recruitment: informants were randomly selected from registration log books at the reception 
of PASADA clinics where all patients had listed their names prior to accessing medical services. 
28 
 
PASADA had children’s clinics run separately from that of adults. In each of the children’s clinics 
a research assistant was stationed at the reception and recruited participants. Every third child 
who came to the clinic were approached and requested for their consent and assent to 
participate in the study and those who accepted were included in the study. Research 
participants were gathered and explained the purposes of the research and that their 
participation would not result into financial benefits or any form of privileges. Research 
participants were given an opportunity to ask questions that clarified the research process. 
Participants were informed that they were allowed to withdraw from the study at any point 
time without being penalized. Each of the children and their parents or guardians who 
participated in the research had their respective verbal assent and written consent obtained 
and each of the interviews was conducted for an average of 30 minutes. 
 
Information relating to response to objective four of the study was obtained through 
researcher administered questionnaires. Each of administered questionnaires was verified by 
the principle investigator within two days after being completed. All questionnaires were 
administered during the first four months of the study (January to April 2011), and individual 
chart reviews were done between August and December 2011.  
 
 Qualitative data: focus group discussion: Objective two and three.  
Recruitment of participants: informants for focus group discussions were recruited through 
purposive sampling from a pool of clients who attended PASADA HIV clinics. Both adults and 
children who participated in the research were approached and asked if they agreed to 
participate in the study. Participants were informed that their involvement were not going to 
result into financial gain or any other form of benefits and rather the information gathered 
from the research is intended to improve delivery of health services in children living with HIV. 
In addition, participants were given opportunity to ask questions on the research and 
clarifications were given. Participants were also allowed to withdraw from the research without 
being penalized as a result of their decision. Written consents were obtained from guardians or 
parents following verbal assent of their respective children. Participants gave the permission to 
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record the conversations during focus group discussions. Participants were informed that 
confidentiality during discussions could not be guaranteed especially during group discussions 
although; research staff was committed to maintain confidentiality by signing a confidentiality 
agreement form whereas research participants were not required to provide the same 
commitment. It took an hour on average to conduct one focus group discussion. Participants 
were given money to compensate the cost for transportation and the time spent for the 
research.    
 
Focus Group Discussion procedures: children had their focus group discussions conducted 
separately from that of adults. Children of age groups 8 to 13, and 14 to 18 years had their 
group discussions conducted separately according to the research protocol. Decision to 
separate the two groups of children based on their age was made to favour those with closely 
related milestones to be in same group discussion to allow robust interactions among 
participants. Each of the group discussion had two research assistants: one as a facilitator, and 
another as a note taker.  The focus group discussions comprised of 6 to 8 participants and at 
least three participants were identified through each of IPCF and VCT approaches.                                                                                                                                                                                                                                                                                                                       
 
The topics that guided the discussions were on HIV social implications, perceptions on HIV 
services, and HIV health related outcomes. The conversations in the focus group discussions 
were tape recorded by the analogy Sony Cassette Recorder devices. Field notes were also taken 
where non-verbal actions and emotions were as well captured. A total of 10 focus group 
discussions were conducted among children aged 8 to 13 and 8 focus group discussions among 
children aged 14 to 18 years, while 12 focus group discussions were conducted among 
guardians. During focus group discussion conversations, research assistants ensured that 
comparisons were made between participants in the IPCF and VCT groups to ensure that each 
of the topics was covered throughout all 30 focus group discussions we conducted.  
 
Subsequent group discussions were conducted until a point of data saturation was reached. 
Transcription was done verbatim by one of the six research assistants who were not involved in 
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actual group discussions. Each of the transcripts was then reviewed by at least one of the five 
research assistants. In addition, the principle investigator randomly listened to the recorded 
conversations and did a comparison with the transcripts for accuracy. 
 
All transcripts were translated by the principle investigator from Swahili to English before 
analysis was done and translations were verified by an independent reviewer. 
 
2.9. Data Analysis 
 Survey data 
We developed a Microsoft Excel spreadsheet with variables which were present in the 
questionnaire. All variables for 227 respondents were imported to a spreadsheet and data were 
saved as an Excel Workbook. Different codes were then generated for identification of 
participants and the column with client’s registration number was dropped to maintain 
confidentiality.  A new Excel workbook was generated and used by the researchers throughout 
data analysis. The excel sheet was then uploaded in STATA software Inc. 12 for analysis. We 
made comparisons of two groups IPCF and VCT on social and health characteristics in response 
to object four for variables such as: sex, number of parents currently alive, education level of 
the child, adult accompanied the child to a clinic, time spent travelling to a clinic, primary care 
giver status, CD4 count at first clinic visit, number of health care providers visited by prior an 
HIV diagnosis, time interval from diagnosis of HIV and disclosure, linkage to specialized services, 
WHO clinical stage at first visit, ARV status, opportunistic infections preceded an HIV diagnosis 
and status of the accompanied guardian. We ran a Pearson Two Sided T-Test to make a 
comparison on the children’s characteristics between IPCF and VCT groups. We used the 
Pearson T-test (parametric test) based on the assumption that the sample size we used to 
compare characteristics of children of adequate size and had followed a normal distribution. 
Each of the children participated in the study had a chance to be identified by either of the two 
approaches IPCF or VCT therefore analysis of the data was done according to the methods of 
identifying their HIV positive status.      
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In response to the study objective one, we assessed the effect of IPCF intervention on the 
number of children who were tested HIV positive and enrolled in HIV clinics seven months 
before and seven month after the IPCF intervention. This information was obtained from the 
PASADA electronic data base.   
 
In additional we assessed the effect of IPCF intervention on the number of HIV-positive children 
who were initiated anti-retroviral drugs seven months before and after the IPCF intervention. 
We ran a Kruskal-WallisTest to assess the statistical differences in the two time periods. We 
chose this non parametric test because participants in the two periods had a chance to be 
counted twice and comparison was made on ranks (months) of seven months. We therefore 
could not make an assumption on the distribution of population before and after intervention.      
 
In answering study objective four we used odds ratio (IPCF/VCT) in order to compare the 
characteristics of children in the IPCF and VCT groups.     
 
 Qualitative data 
Familiarization: 
Researchers participated in the focus group discussions which facilitated an initial 
understanding of the researched subject. Following verbatim transcription and translation of 
the conversations, transcripts were read repeatedly by the team to enhance familiarization of 
its contents.   
In the whole process of transcription and rereading of the transcripts, researchers avoided to 
comment or categorize the information in order to reduce the chances of their personal 
influence on data analysis. The research team were very familiar with the types and location of 
particular information in the text the fact that enhanced development of themes and sub-
themes.  
Issues: 
While familiarization with the data continued, researchers started to identify phrases with 
complete messages and each of the phrases was highlighted with different colours. The phrases 
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were assigned codes indicating which parts of the interview they had been taken from. Phrases 
were then cut and those with close related messages were grouped and posted on the wall 
under one heading describing the contents and resulted into topics. While generating themes 
researchers did not find easy to organize phrases which had cross-cutting messages. Also, 
grouping of emotional expressions from participants was not easy.  
Themes: 
Different messages in each of the groups were studied and rearranged to formulate a logical 
flow and linkage of ideas. A total of three themes were eventually generated through re-
arrangement of thoughts and messages which were captured during focus group discussions.    
Sub-themes:  
Content analysis of the themes was done by researchers and information with closely related 
messages was merged under each of the themes to formulate sub-themes. We constantly 
reviewed the contents of sub-themes and comparisons were made between chosen sub-
themes to ensure sub-themes with significant information were retained. Organization of sub-
themes was done to ensure a logical flow of ideas is maintained. A total of thirteen sub-themes 
were generated.   
Reflexivity: 
Researchers are part of service delivery of the paediatric division in a study site; therefore, 
personal judgements that could influence data analysis were addressed by reminding 
researchers to remain neutral and non-judgemental in every step of the research. 
Internal validity: 
The choice of research tools; focus group discussion and structured questionnaire was made to 
ensure internal validity of the research. The use of focus group discussion enabled researchers 
to better understand the group dynamics and gather rich information which on the other had 
helped researchers to understand the topic and enhanced administration of questionnaires.    
    
2.10. Data storage privacy and confidentiality 
Unique identification (ID) numbers were allocated to all research participants and all identifiers 
were kept separate from the data which were used for analysis. Questionnaires, cassettes and 
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field notes were also labelled and stored in a locked cabinet and access to research material 
was restricted to the research team members only.  Electronic data were stored in an external 
hard drive and access to the information was password-protected and strictly limited to the 
research team. The research materials will be destroyed in a five year period following 
dissemination of the research findings.    
  
2.11. Ethical considerations  
Children and guardians participated in the research were fully informed on the purpose of the 
research and that there were no financial or other form of gain as a result of participating to 
the study. They were also provided with ample time to ask questions pertaining to the study, 
and clarifications were provided. Participants were assured that any of their decision to 
participate in the study or withdraw from the study at any point was not going to affect the 
care they are entitled to get from PASADA. Participants were allowed to withdraw from the 
study if at all they chose to do so. Children who were enrolled in the study and identified with 
health problems were provided with assisted support that linked them to appropriate channels 
of care.  If children exhibited psychological stress during interview process, researcher 
assistants would terminate the process and refer the child to appropriate channels of care.  
Permission to conduct this research was obtained through the Tanzania National Institute for 
Medical Research.   Ethical approval from the University of Cape Town FHS HREC #363/2010 
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CHAPTER THREE: Results 
The results are presented in two parts: quantitative data relevant to objectives 1 and 4 and 
qualitative data relevant to objectives 2 and 3. The quantitative data is presented in table 1, 2, 
and 3 and qualitative data in table 4. Table 1 presents social and demographic data, whereas 
and table 2 presents information on health characteristics of children participated in the study. 
Data on the impact of the IPCF approach on the PASADA programme is presented in table 3 and 
that on the experience of living with HIV among research participants is presented in table 4. 
 
6.1. Quantitative results 
6.1.1. Social and demographic characteristics. 
A total of 227 participants were enrolled in the study (VCT=76 and IPCF=151), which is beyond 
the required sample (204). The average ages of children participants in the IPCF and VCT groups 
were 11.3 and 12.3 years respectively (P-Value 0.007). There was no difference in proportions 
participants based on their sex. The proportions of males in the IPCF and VCT were 51% and 
50% respectively, and that of females were 49% and 50% for the IPCF and VCT groups 
respectively (P-Value=0.89). IPCF group constituted 12%, 77%, and 11% of children with none, 
primary, and secondary levels of education respectively, while, those in the VCT constituted 
16%, 43% and 41% of children with none, primary, and secondary levels of education 
respectively (P-Value 0.049). In the IPCF and VCT groups 82% and 88% respectively, spent less 
than 3 hours travelling time to the clinic whereas 18% and 12% in the IPCF and VCT, 
respectively, spent over 3 hour time travelling to the clinic (P-Value=0.26). A majority of 
children in the IPCF were cared by biological parents compared to children in the VCT group. Of 
those who were interviewed, 45%, 21%, 25% and 9% in the IPCF group and 37% 29%, 26% and 
8% in the VCT were cared by biological parents, aunt/uncle, grandparents, and non-relatives 
respectively (P-Value=0.48) Table 1.  
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Table 1: Demographic characteristics of study participants 
Variable IPCF (n=151) VCT (n=76)        Odds 
Ratio 
P-value 
Number 
(n) or 
mean 
(%) or 
SD 
Number 
(n) or 
mean 
(%) 
or SD 
IPCF/CVT 
Sex 
     Male* 
     Female 
 
77 
74 
 
51% 
49% 
 
38 
38 
 
50% 
50% 
 
 
0.96 
 
0.89  
Age 11.3 3.5 12.6 3.4 0.89 0.007  
Number of parents currently 
alive 
     Two*
 
     One 
     None 
 
 
35 
63 
51 
 
 
23% 
42% 
34% 
 
 
12 
33 
31 
 
 
16% 
43% 
41% 
 
 
 
0.7 
0.6 
 
 
0.39  
Education of child 
     None* 
     Primary school 
     Secondary school 
 
18 
116 
17 
 
12% 
77% 
11% 
 
7 
51 
18 
 
9% 
67% 
24% 
 
 
0.9 
0.4 
 
0.049  
Time spent travelling to clinic 
     0 to 3 hours* 
     > 3 hours 
 
120 
26 
 
82% 
18% 
 
66 
9 
 
88% 
12% 
 
 
1.6 
 
0.26 
Primary caregiver 
     Biological parent* 
     Aunt/Uncle 
     Grandparent 
     Non-relative 
 
68 
31 
38 
4 
 
45% 
21% 
25% 
9% 
 
28 
22 
20 
6 
 
37% 
29% 
26% 
8% 
 
 
0.58 
0.78 
0.96 
 
 
0.48  
Accompanying adult at a clinic 
     Biological parent* 
     Aunt/Uncle 
     Grandparent 
     Non-relative 
 
64 
39 
33 
15 
 
42% 
26% 
22% 
10% 
 
28 
23 
18 
7 
 
37% 
30% 
24% 
9% 
 
 
0.74 
0.8 
0.9 
 
 
0.84  
*
Reference group 
6.1.2. Health characteristics: 
Children in the IPCF and VCT who had CD4 count above 500 cells/ml were 42% and 34% and 
those with CD4 count less than 200 cells/ml were 33% and 33% respectively (P-Value=0.611). 
The research depicts a significant difference in the number of hospital visits made by children in 
the IPCF and VCT groups. Children in the IPCF group had multiple hospital visits suggesting that 
they were likely to be missed by the VCT approach. We found 46% and 31% of children in the 
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IPCF and VCT visited over 3 healthcare providers prior to an HIV diagnosis (P-Value 0.001). Lack 
of disclosure of HIV status to children was prevalent in the two groups, however; more children 
in the IPCF (46%) compared to 29% in the VCT had undisclosed HIV status (P-Value=0.005). 
There was no difference between the two groups on the number of children who were initiated 
on anti-retro viral treatment. The commonest opportunistic infection reported among children 
in both groups were upper respiratory tract infections 39% (for both IPCF and VCT groups and 
skin infections 34% for the IPCF and 38% for the VCT groups (P-Value= 0.478). Other health 
characteristics are presented in table 2. 
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Table 2: Health characteristics of study participants 
Variable IPCF (n=151) VCT (n=76) Odds ratio p-value 
Number 
(n) or 
mean 
(%) or 
SD 
Number 
(n) or 
mean 
(%) or 
SD 
IPCF/VCT 
CD4 count at first visit (c/ml) 
     > 500*
 
     350-500 
     200-350 
     < 200 
 
63 
15 
23 
50 
 
42% 
10% 
15% 
33% 
 
26 
10 
15 
25 
 
34% 
13% 
20% 
33% 
 
 
0.8 
0.7 
0.6 
 
0.611 
Number of healthcare 
providers visited prior to HIV 
diagnosis 
    None* 
     1-2 
     3+ 
 
 
 
27 
54 
70 
 
 
 
18% 
36% 
46% 
 
 
 
34 
18 
24 
 
 
 
45% 
24% 
31% 
 
 
 
 
3.5 
4.5 
 
 
 
0.001  
Time interval from diagnosis 
of HIV-status to disclosure 
(months)  
    0 to 3* 
     4 to 6 
     > 6 
     Not done 
 
 
 
20 
18 
43 
68 
 
 
 
13% 
12% 
29% 
46% 
 
 
 
24 
6 
23 
22 
 
 
 
32% 
8% 
31% 
29% 
 
 
 
 
3.6 
2.2 
3.7 
 
 
 0.005  
WHO Clinical stage  
    Stage I* 
     Stage II 
     Stage III 
     Stage IV 
 
19 
91 
33 
8 
 
13% 
60% 
22% 
5% 
 
16 
41 
13 
5 
 
21% 
55% 
17% 
7% 
 
 
1.9 
2.1 
1.3 
 
0.332 
ARV Status 
     Currently taking ARV* 
     Not currently taking ARV 
 
90 
61 
 
60% 
40% 
 
45 
31 
 
59% 
41% 
 
 
0.98 
 
0.955 
Initial diagnosis 
     Malnutrition 
     Tuberculosis 
     Skin 
     Respiratory 
     GIT 
     Other 
 
4 
7 
51 
59 
20 
13 
 
1% 
5% 
34% 
39% 
13% 
9% 
 
1 
4 
28 
29 
4 
10 
 
4% 
5% 
38% 
39% 
5% 
13% 
 
0.4 
0.6 
1.1 
1.1 
1.3 
3.1 
 
0.478  
*
Reference group 
A multiple logistic regression was run to assess the odds of health providers visits made by 
children in the IPCF group compared to those in the VCT. After adjusting for age and sex, the 
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children in the IPCF group had over 5 times odds of visiting more than three health care 
providers compared to those who were in the VCT group (P-Value < 0.001) Table 3. 
Table 3 IPCF/VCT Logistic regression results, selected characteristics IPCF study, 2012 
  Un adjusted odds ratio  Adjusted odds ratio 
Variable  OR P-Value SE OR P-Value* 
Intercept 9.0 
 
10.13 
 
  
  
    
  
Age 0.89 0.008 0.046 0.87 0.007 
  
    
  
Gender 
    
  
Male 1 
   
  
Female 0.96 0.8877 0.376 1.2 0.651 
  
    
  
Number of facilities visited 
prior to start HIV clinic 
    
  
None 1 
   
  
One 3.5 0.004 2.619 5.4 0.001 
Two 4 0.005 3.353 6 0.001 
≥Three 4 <0.0001 2.103 5.2 <0.0001 
*P(Value  adjusted for Age, Sex, Number of facilities visited,  
OR (Odds ratio) 
SE (Standard Error) 
 
Figure 3: Distribution of CD4 count by identification approach (IPCF vs VCT) 
 
IPCF group has children with both higher >500 and lower <500 CD4 count and majority of 
children in the VCT group have low CD4 count (P-Value >0.5) 
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6.1.3 Impact of the IPCF on the PASADA programme. 
On average 28 children and 48 children respectively tested HIV-positive per month for the 
period of seven months before and after the IPCF intervention (P-value 0.001). Also on average 
19 and 27 children were respectively initiated anti-retro viral treatments seven months before 
and after the IPCF intervention was implemented (P-Value 0.02) Table 4.  
 
Table 4: Children tested HIV-positive and enrolled in a PASADA care and treatment center  
Children tested HIV-positive and started on anti-retroviral treatment 
Year-2009 (Before IPCF)  Year 2010 (After IPCF) 
Month Children Tested HIV-Positive 
Ц=28, SD=4.7 
 Month Children Tested HIV-Positive 
Ц=48, SD=7.8 
June 24  January 41 
July 33  February 49 
August 23  March 47 
September 32  April 43 
October 28  May 64 
November 32  June 48 
December 22  July 42 
Ц-Mean , SD- Standard deviation 
A sustained increment of number of HIV positive children who were enrolled in a PASADA 
program seven month after start of the IPCF intervention compared to seven months before 
implementation of the intervention.   
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Table 5: Children tested HIV-positive and started on ART at PASADA clinics   
Children tested HIV-positive and started on anti-retroviral treatment 
Year-2009 (Before IPCF)  Year 2010 (After IPCF) 
Month Children Initiated ART 
Ц=19, SD=2.6 
 Month Children Initiated ART 
Ц=27, SD=5.7 
June 18  January 17 
July 22  February 23 
August 19  March 34 
September 20  April 27 
October 21  May 32 
November 14  June 27 
December 18  July 29 
Ц-Mean , SD- Standard deviation 
Table 5 shows increased number of children tested HIV positive that are initiated on ARV. 
However, a low proportional of children who are initiated on ARV is seen in the seven months 
after implementation of the IPCF intervention. The low proportion could be explained by the 
short study period; also initiation of ARV requires a thorough assessment of social and clinical 
wellness of both the children and their guardians and it is a time consuming. Also despite a 
huge number of HIV positive children identified by the IPCF intervention, these children may 
also not qualify for ARV due to low CD4 count or other health reasons.     
 Figure 4: Children enrolment PASADA clinics by period (7 months Before vs After IPCF) 
 
P-Value =0.001 
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More children were tested HIV positive and subsequently enrolled in a PASADA care and 
treatment programme. 
 
6.2. Qualitative findings 
A total of 30 focus group discussions were conducted: 10 for children aged 8-13, 8 for children 
aged 14-18 years and 10 for guardians and parents. Table 6 summarizes characteristics of 
participants of involved in the FGD. 
 
Table 6 Characteristics of participants in focus group discussions, IPCF study 2012 . 
Focus 
group 
Number 
of FGD 
No. of 
participants 
Average  
age 
(Years) 
Gender Mode of diagnosis 
Male Female IPCF VCT 
8-13 10 122 12.5 42 84 87 35 
14-18 8 62 16 30 32 20 42 
Guardians 12 129 48 57 72 74 55 
 
Three themes and thirteen sub-themes were generated as summarized in table 6. 
Table 7: Themes analysis IPCF study 
THEME ONE THEME TWO THEME THREE 
HIV Social implications  HIV services  Health outcomes 
I. Parental loss I. Poor adherence  I. Improved health status 
II.  Attachment  of children   II.  Children concern about lack of 
disclosure  
II. Recurrent illnesses 
III.  Stigma and discrimination  III.  Approach to HIV identification   
IV.  Witch craft IV.  Disclosure at a household    
V. Children social 
responsibilities 
V.  Legal services    
 
THEME ONE: HIV social implications 
I. Parental loss 
Many children appeared to have experienced a loss of one or both of their biological parents. 
This observation persisted in both groups of children aged 8 to 13 and 14 to 18 years. However, 
fewer children in the older group (14 to 18) reported to have living parents. A 14 year old 
female child, identified through IPCF said,  
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“I am very sad [low tone], my mother died when I was in standard six, she left 
me with my two siblings. My dad also died two years later and I moved and 
stayed with my aunt. Shangazi [Aunt] could not stay with me as she said, I was 
too ill and therefore she sent me along with her friend to her sister who is my 
other aunt as well... Shangazi mdogo [Aunt’s sister] took me to my 
grandmother for a short period I stayed with her. I was still sick and thank you 
for [name of volunteer] who advised my grandmother to bring me to PASADA. 
Now I don’t get sick as I used to, and I am now going to school”.   
                                        Participant 4: FGD 10 
      
The research revealed that guardians who were biological parents were more likely to have 
children of a much younger age compared to guardians who were not biological parents. A 16 
year boy identified through VCT said,  
“My father passed away before I started primary school and together with my 
mother and my siblings we went to stay with my uncle. The life thereafter 
became so difficult we moved to [name of town he live] and we established small 
business for income generation. Then my mother died...Now I am able to go back 
to school after joining PASADA programme”.                                         
                                    Participant 1: FGD 12           
       
II. Attachment of HIV positive children 
Majority of children had moved over three times between different caregivers. A 13 years boy 
identified through VCT said,   
Before I stayed with my grandmother, I lived with uncle [name], my sister and my 
aunt who live in [name of a place] and I was very sick. My sister and my aunt 
brought me back to Dar where I stayed with my grandmother…”  
Participant 3: FGD 1 
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The same phenomenon of shifting between different family members was reflected in both 
children and adults focus group discussions. One grandparent guardian said,   
Mjukuu wangu [my grandchild] before he came and stayed with me had stayed 
with his uncle, his sister and his two cousins. I could hardly tell what was wrong 
with him until when I was advised to come to PASADA and tested him….”  
Participant 4: FGD 21          
 
While shifting between caregivers, most children stayed with their paternal uncle or aunt as a 
primary care giver following a parental loss. Other members of the family often came later in 
the series. A sixteen year old girl said, 
“After the loss of both of my parents, I stayed with my uncle and my aunt. My 
aunt brought me to PASADA and she told me to come to PASADA whenever I get 
sick…”         Participant 3: FGD 16 
The trend of shifting for many children ceased when children were cared by grandparents. A 
small proportion of children had lived with people who are not biologically related to the child.  
One family friend guardian said,   
“…Mwanangu [name of the child] is very close to my children and after a loss 
of both their parents who were very good friends of my family; we decided to 
stay with [name of the child] and now she goes to school just like her fellows” 
         Participant 6: FDG 22            
III. Stigma and discrimination 
Stigma and discrimination were featured in both adults’ and children’s group discussions. 
Guardians, in particularly, reported stigma being one of major challenges of living with a HIV-
positive child and it is prevalent at a family, community and work places. A number of guardians 
had associated stigma with financial constraints they encountered. Guardian of 8 year old boy 
whose child were identified by VCT approach said,     
“I used to work as a secretary for a business company and when my son was 
diagnosed with HIV, I had to quit the job that I had in order to take good care 
of my son as needed. I did not want anybody to know the status of my son in 
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order to protect him from being discriminated by other people. It is very hard 
[pause] em... For instance I have no reliable income to sustain my life and 
keep up with living expenses; I have nobody to support me and my 
relatives…”                                
                                                                         Participant 2: FGD 19 
      
Episodes of stigma and discrimination were also prevalent amongst children of age 14 years 
and above.  Thirteen year old boy identified by VCT said,  
“I was very disappointed by other pupils who made fun of me, they were 
picking on me. They were, calling me names such as ‘mama VVU’ [Swahili 
word means mother of HIV] and some did not let me play with them.” 
             Participant 3: FGD 2 
 
 At a house hold level, children had reported to experience being stigmatized by their caregiver. 
A 16 year old child reported to be socially discomfort with the way how his aunt took care of 
him when compared to other siblings. A 14 year old boy identified through the VCT approach 
said, 
“My aunt used to wear plastic bags on her hands when she was washing my 
cloths…. I could see her through the window as she did not do openly. She 
separate my cloths with that of other children, I was very sad and asked why… 
and I did not get an answer clothes until when [name of doctor] had decided to 
conduct a meeting with my family and therefore my aunt stopped the behaviour”   
Participant 5: FGD 3  
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IV. Witchcraft and HIV 
Existence of belief that associated HIV with witchcraft was featured in group discussions of both 
adults and children. None of the guardians admitted directly to be involved in the practice, 
although, participants admitted that the practice existed. A guardian of a 16 year old girl said, 
“My child started to experience recurrent illness when she was in her first year of 
secondary education and her aunt suggested that she was bewitched, however; I 
did not believe to be the case... and I brought her to PASADA and now she is 
progressing well”       Participant 2: FGD 11  
 
Similarly, children mentioned that they knew people who associated HIV with witchcraft. 
One child said,  
“I was very sick… and my grandmother used to tell me I was witched and that 
being a major reason for my illness. My sister took me to PASADA and that was 
the end of my illness, now I have no more fever and pain”  
Participant 3: FGD 6 
V. Children social responsibilities 
We found, majority of children who were full orphaned assumed more social 
responsibilities such as keeping of medical records, preparing food for the family, and 
taking care of other siblings. A 16 year old boy said, 
“I stay with my grandmother and my three siblings in [name of a place] and I 
prepare food for the family, fetch water before I go to the school and go to the 
clinic…”          Participant 3: FGD 18 
 
THEME TWO: HIV Services 
I. Poor adherence to antiretroviral drugs (ARV) 
Poor adherence to ARV in children was evident in the children’s discussions. Children expressed 
the feelings of hating taking the ARV especially when there was not adequate information that 
describe the reasons for taking the drugs.    
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My mother used to tell me to take the drugs, but I did not like them. I used to get 
sick and the doctor told me it is because I have not been taking the drugs 
properly. Now I take the drugs and my health is good…”  
Participant 2: FGD 8 
 
II. Children concern about lack of disclosure 
A concern of the lack of openness in guardians on the topic of disclosure was reported by most 
of the older children (14 to 18 years). A 17 year old boy said,   
I used to ask my aunt what was wrong with me… I decided to test for HIV during 
presidential campaign and I was told that I am infected with HIV…” 
                                                                                                                Participant 6: FGD 18   
  
Also, guardians were reported by children to be reluctant in disclosing HIV to children.  
“I asked mama mdogo [step mother] why was I taking medicines every day, and 
neither of my siblings were taking them, mama mdogo-told me that I had chest 
problem so I had to take them. I asked her why was I taking them continuously 
even at times that I was not ill,…she told me the drugs were for preventing the 
illnesses I was born with, and insisted I have to take them ..Eh, but I hate them. 
My doctor was also telling me to take them”. 
         Participant 1: FGD 18    
 
A number of older children knew their HIV status at a younger age and they were conversant to 
talk about issues related to their health.   
 “I heard a doctor speaking about HIV every day when I came in the clinic…and I 
asked a doctor in the pharmacy [ARV dispensing nurse] and she explained to me 
that I was infected with HIV…”     Participant 5: FGD 17 
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III. Identification of HIV positive children 
HIV tests amongst children were often preceded by symptoms of recurrent illnesses. Majority 
of children had experienced episodes of recurrent illnesses before an HIV test.   
“I used to get chest pain, diarrhoea very often until when my aunt decided to 
bring me to PASADA and I was tested for HIV. Now I am I am doing fine…”  
Participant 4: FGD 13 
An expression that an HIV diagnosis was delayed featured in adults’ group discussions. Several 
guardians reported to have made repeated hospital visits and others lost their children, 
nonetheless; an HIV test was still not conducted. One of the guardians reported to have been 
frustrated by the systems of testing children which she claimed to have resulted to loss of her 
two children. During conversations, guardians and parents whose children were identified 
through IPCF appraised the system and considered as a saviour to their children. One biological 
parent said,    
 “I lost two of my children who were ill for a while. My first born was four years 
old and my second born was three. They both had [paused and wiped tears] 
…every time when I went to a doctor, the doctor told me that my children had 
malaria and pneumonia, I wish the doctor had tested them for HIV [paused with 
deep sorrow. I think they would have not passed away, thank you [name of staff] 
and thank to PASADA….my son couldn’t be healthy without …” 
Participant 2: FGD 23   
 Missed opportunity for an HIV test among children was also revealed in the adults’ group 
discussions. Many guardians had a notion those older children who had no history of recurrent 
illnesses, had a negative HIV status in spite of the HIV positive status of the parents. One 
biological parent said,     
“ I have so much to thank to PASADA for initiating a test to my child as I had 
never thought kijana wangu [older son] would possibly be infected with HIV as 
well… as he had no any problem problems… yaani [thrilled with the situation] oh! 
Oh! Thank you for opening my mind and rescuing my family” 
Participant 2: FGD 24 
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IV. HIV disclosure at a household level. 
Biological parents who participated in the discussions had a similar pattern of HIV disclosure 
between partners and their children. A biological parent of a child identified through the IPCF 
said,  
“I am a mother of three children; I received an HIV test for the first time three 
years ago and after a year I decided to share with my late husband who was also 
tested. We both joined a PASADA clinic… and this year through a support of [staff 
name] all three children were tested…” 
Participant 3: FGD 20 
Most of the times it followed that; one parent, would know his [her] HIV status followed by the 
second parent and the child would come last. A 16 year old girl said,   
“Before the death of my mother due to HIV, my mother spoke to my sisters and 
told them that they should take a good care of me as I will be the neediest one in 
the family… I was immediately tested for HIV after my mother’s death, and now I 
am healthy and progressing in school”         Participant 6: FGD 15    
 
V. Legal services 
Many barriers to accessing legal services existed among guardians of HIV-positive children. A 
number of children expressed their concern on the ways families handled issues that relate to 
family inheritance. A child from a 14-18 year FGD said,  
“After a loss of my father, I stayed with my mother and we were told to stay with 
baba mdogo[ paternal uncle]. Most of our properties such us house furniture, 
shop, farm land were forcefully taken by relatives and other people, it is very sad 
that we could not recover our belongings [reduced tone]…”  
Participant 4: FGD 5 
  
Episodes of losing family possessions forcefully to people who were initially known to be friends 
or relatives to the family were common. One female guardian reported that   
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“Immediately after a loss of my husband, I have been struggling to recover our 
house, farm land… we owned with my husband. Shemeji na wifi zangu [brothers 
and sisters to her husband] came and forced me out of the house… I was 
threatened [deep sorrow] to be prosecuted if I had attempted to claim anything…”  
Participant 4: FGD 7 
 
THEME THREE: Health outcomes 
i. Improved health status 
Most of the children in both IPCF and VCT groups reported to have improved their health 
following an HIV test. Similar trend of information was reported in both children and adults 
group discussions. Children reported to have less opportunistic infection and less school 
interruptions after receiving an HIV test. A 16 year old child said, 
 “My legs were hurt and I had a very back headache. My nose was bleeding 
especially...my mother brought me to PASADA and I was given treatment by 
[name of heath care provider] and all problems went way. I am going to school 
and I want to be a pilot...”  
Participant 6: FGD 5 
Likewise after receiving an HIV test, biological parents and guardians expressed to have less 
incidences associated with stigma and their children were more socially interactive to the 
environment compared to the times before an HIV diagnosis was made.  
“I had to go to the hospital almost every day single and it was somehow a 
challenge with my work... Also my son could not play with fellow because of 
being ill most of the time. But after joining PASADA and doctor [name of staff] 
helped so much and now my son comes to the hospital by himself and he goes to 
school and play with his fellow comfortably...” 
                                                                                      Participant 6: FGD 10 
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II. Recurrent illnesses 
Majority of children encountered episodes of recurrent illnesses prior to an HIV test.   
Children who were cared by biological parents as compared to those cared by guardians other 
than biological patents were more likely to report fewer episodes of illnesses which were also 
less severe. One biological parent said,   
“After when I and my husband were tested HIV positive we decided to test our 
two children, one was found infected and the other one was not infected…” 
Participant 4: FGD 9 
Recurrent illnesses were mentioned by majority of guardians as a major challenge of caring a 
HIV-positive child. One grandparent guardian said,    
[Name of a child] has been getting fevers, and it is usually very difficult to take 
him to the hospital and leave his other three siblings. I sometimes send to the 
hospital by himself…”       Participant 1: FGD 10 
iii. Summary results  
These findings demonstrate that more children were identified and enrolled in a PASADA 
programme after implementation of the IPCF intervention. These findings help PASADA 
program to realize the need for active measures to initiate children on ARV. Also children in the 
IPCF and VCT groups differ in their social demographics and health characteristics. Three 
themes related to health services, social implications and health outcomes were generated 
during focus group discussions and these are discussed in detail in the next section of the 
report.   
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CHAPTER FOUR: Discussion 
HIV/AIDS is still a huge problem and has caused more deaths in children than any other 
diseases in the sub Saharan African. Access to HIV services is still a major barrier to achieving 
millennium development goal number four to reduce child mortality. This research was 
designed to evaluate the impact of the IPCF program on identification of HIV positive children. 
In conducting this evaluation: we assessed the impact of IPCF in identification of HIV positive 
children, determined perception of the guardians on approaches for HIV identification of HIV 
positive children, assessed experience of living with HIV among children and their guardians 
and compared social and health characteristics of children in the IPCF and VCT groups. We 
found much younger children were identified thus a possibility of setting a better plan of care. 
We also found existence of many socials challenges similar to what has been reported by 
authors in previous studies thus we recommend another study which will allow comparison of 
the outcomes of the IPCF intervention at PASADA and program s in different settings.    
 
In this chapter, we discuss programmatic and policy implications from the study findings and 
provide recommendations in order to improve access and utilization of medical services in 
children living with HIV. 
4.1. Age of children  
Children identified through IPCF intervention are much younger compared to those identified 
through the VCT intervention. Over 80% of HIV infections in children in Tanzania occur through 
vertical transmission and many of these children have been reported to miss opportunity for an 
HIV test (WHO, 2010) until they reach an older age. UNICEF reported poor coverage of PMTCT 
programme in countries such as Nigeria [3%] and Tanzania [15%], and a moderate coverage in 
South Africa [50%] (UNICEF, 2008). A low coverage of PMTCT services has resulted in many 
children being born to HIV infected mothers who never tested for HIV and never received 
PMTCT prophylaxis. Kellerman & Essajee (2010) have reported that it is unlikely that these 
children will be identified unless there is a targeted testing strategy. 
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A delayed diagnosis of HIV has been associated with poor health outcomes such as high rates of 
opportunistic infections, poor adherence to treatments and death (Wortley et al., 1995:487). 
The ability of the IPCF intervention to identify younger children has important implication to 
the national and international efforts to reducing child mortality in order to achieve the 
Millennium Development Goal number four (Global Health Workforce Alliance, 2010).  
Integration of the IPCF intervention with other traditional approaches (VCT and PICT) in systems 
for identification of HIV positive children would improve identification of children who are HIV 
positive.  
4.2 Approaches of HIV identification  
The overall impact on the health outcomes of children following an HIV test regardless of the 
approach used was good as such children and guardians reported less episodes of recurrent 
illnesses. The key differences between IPCF and other traditional approaches for identification 
of HIV positive children (VCT) and provider initiated counselling and testing for HIV is that unlike 
the traditional approaches, IPCF does not wait for a children to come to health facilities to 
initiate an HIV test and rather it tracks children when they are still at the community they live 
and provide links to health facilities. The IPCF involves medical and non-medical personnel 
provided that they work in a health facility. Unlike other traditional approaches, IPCF involves 
patients’ relatives, visitors to health facilities, volunteers, friends of health care workers, 
community groups such as churches and mosques, and local government entities. The IPCF also 
uses unique and unspoken social attributes that exist within communities to identify those 
children who are at higher risk of HIV positivity. In addition, IPCF created an atmosphere that 
neutralized a perceived worry by health care providers of disclosing family secrets by 
conducting an HIV test thus health care providers, guardians and parents were actively engaged 
in the IPCF process. Authors have brought attention to the benefits of exploring multiple 
sources of support, both personal (e.g. children’s friends, caregivers’ peers) and institutional 
(e.g. schools) for addressing many challenges that limit accessibility and the use-ability of 
medical services by HIV positive children (WHO, 2011). In addition, WHO recommended a 
family-centred approach for HIV testing to ensure a maximal use of opportunities to identify 
HIV exposed and HIV infected children (WHO, 2010) something that features in the IPCF 
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intervention. In summary, the IPCF approach provides a wider scope for communities to 
actively participate in identifying HIV positive children and bring them to appropriate medical 
care. However, it is important to understand that there are similarities between IPCF and other 
traditional approaches in that these approaches are implemented according to the national 
guidelines for HIV testing which requires health care providers to obtain consent from 
children’s parent or legal guardian and they both use same biological tests to confirm presence 
the infections.          
 
Implementation of the IPCF intervention started by sensitizing the management team and 
health care workers of PASADA on the need for improving access to HIV testing among children 
and its implications to reducing child mortality.  Providers were explained what is expected 
from them and they were allowed to ask questions on the process of implementation. 
Providers were requested to ask three key questions to PASADA visitors, relatives, and friends 
and these were referred as IPCF contacts. Prior to start of the IPCF, majority of health care 
providers were reluctant and had feared that the approach was going to expose children and 
breach confidentiality. Many providers had thought that guardians or parents of identified 
children were not going to accept and the process might lead to negative legal implications. 
Instead it turned out that the communities and families interpreted the IPCF as the way of 
helping children who were rather suffering and were helpless. The IPCF approach was accepted 
the fact that was revealed during adult and children focus group discussions.  Many guardians 
and parents expressed their appreciations to PASADA staff that facilitated an HIV test to their 
children.  
 
The research found most of HIV tests in children were preceded by episodes of recurrent 
illnesses in spite of multiple hospital visits, many children were still missed the opportunity for 
an HIV test. This finding aligns with previous reports, for instance, according to the World 
Health Organization (WHO) report of 2008, only 8% of HIV-exposed infants received early 
virological testing in 2008 (WHO, 2009). Also a study conducted in Zimbabwe to assess the 
effectiveness of provider initiated HIV counselling and testing showed children are identified at 
a very late stage of HIV disease progression (Topp et al, 2012: 1735). Analysis of international 
54 
 
cohort data on HIV testing in children confirmed that very few HIV infected children are started 
on antiretroviral therapy; and those children who receive ART are started on treatment when 
they are already very sick, largely due to a delay in HIV testing (Sutcliffe et al, 2008:877). Among 
other reasons authors have attributed to a delayed diagnosis of HIV in children include: weak 
health systems Kellerman & Essajee (2010) and an existence of beliefs that associate HIV and 
witchcraft (Allen, 2007:359).  
 
According to the government of Tanzania, health care providers are required to initiate an HIV 
test for children with recurrent illnesses through the provider initiated counselling and testing 
for HIV.  This approach should be standard and implemented in all health facilities (NACP, 2007, 
WHO, 2010:21). Despite provider initiated counselling and testing be a requirement, its uptake 
by health care providers is very minimal. Similar to this study, a study that evaluated the 
provider initiated counselling and testing in Zimbabwe also reported low rates of practice by 
health care providers and result to late identification of HIV positive being a common practice 
(Topp, 2012: 1735).  The finding that children had attended a health facility on a number of 
occasions is a cause for great concern as it illustrates that health care providers are not 
implementing the PICT approach. This concern is also discussed later in this chapter. 
 
The government of Tanzania recommended that by year 2012, 20% of people living with HIV 
who are initiated on antiretroviral treatment to constitute children (HSHSP, 2007:8). However, 
a progress toward achieving this expectation has shown a very minimal change. For instance, 
among the people who were initiated on ART in 2008 and 2009, only 7% and 8% respectively 
were children (NACP, 2011:13). This proportion is way below the expectations. To make this 
recommendation practical and obtain required results, it is important that the government of 
Tanzania implements strategies to ensure all HIV positive children are identified. Achieving this 
goal can be improved through community-based services and community involvement. A 
reported low rate of children on treatment is an indication of gaps in the current traditional 
approaches for identification of HIV positive children. In our findings, we see a direct link 
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between IPCF and increased rates of identification of HIV positive children enrolled in a PASADA 
care and treatment program.    
 
The IPCF approach has shown the ability to identify more HIV positive children, therefore allow 
plan for better care for HIV positive children. When children are identified at an early age they 
also have reduced chance of having advanced stage of HIV disease. Besides physical illness, 
advanced HIV disease also has effects on development milestones of children.  We consider this 
as a cornerstone toward achieving a universal access to ART in children living with HIV. Many 
authors have reported the need for examining different ways to allow identification of more 
HIV positive children early enough in order to increase the percentage of eligible children who 
are initiated on ART (Kellerman, 2010; Laufer, 2006:623). The WHO went further and made a 
call for nations and programmes to consider family centred approaches in order to improve 
access to HIV services in children (WHO, 2010).  
4.3. Level of education 
A difference on level of education in children identified though IPCF and VCT approaches is 
reported. A higher percentage of children in the VCT group reported no formal education (16%) 
compared to those in the IPCF group (12%) (P-Value=0.049). We found children in the VCT 
group were much older compared to those in the IPCF thus are expected to have been enrolled 
in formal education. Children who attend formal school are expected to know more about HIV 
as this is part of the primary school curriculum. Also, older children are expected to be more 
knowledge on HIV from ongoing social marketing such as local and national HIV testing 
campaigns. For instance, in September 2007 the president of Tanzania his excellence Dr. Jakaya 
Mrisho Kikwete launched a national HIV/AIDS testing campaign aimed at ensuring universal 
access to HIV testing to all Tanzanian citizens. The campaign was broadcasted by newspapers, 
radio, television and public addressing approaches (TACAIDS, 2007). Older children and those 
who attend primary school were expected to have more exposure to HIV testing messages than 
younger children and have the potential to influence their guardians and parents to take the 
children for an HIV test. This study found that among children who tested HIV positive, the 
majority of those with formal education were found in the IPCF group and those without formal 
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education the majority were found in the VCT group.   Lack of access to formal education has 
been reported as one of the social predictors of poor health outcomes in orphaned and 
vulnerable children (Mmbando. P, 2010:4). Looking at these findings, it implies that children in 
the VCT group have increased risk for future poor health outcomes contrary to the children 
identified through the IPCF intervention. We postulate that the IPCF intervention is protective 
for the future health outcomes in children. It would be important to follow these groups in 
future to assess the children’s health outcomes.  
 
4.4. Travelling time from home to a health facility 
The research depicted that a large proportion of children in the IPCF (18%) took over three 
hours for travelling from home to the clinic compared to children in the VCT (12%) group. 
Travelling time has a very significant implication to the children’s ability to access HIV testing 
service. Access to health services is associated with costs for bus fare, food and hospital 
charges. Children who reside in a further distance have increased likelihood of having limited 
access to HIV testing services. During our focus groups discussions we found majority of 
children encountered financial crisis and at some point children had to take social 
responsibilities and become bread winners of their families due to financial crisis encountered 
by their families. When access to HIV services relies on the availability of money, the children 
who reside at a further distance are more likely to have limited access to the services. This fact 
is evident in our research findings as such, majority of children in the IPCF group live in a further 
distance compared to those in the VCT group. It is possible that further distance had limited the 
majority of the children in the IPCF group their access to HIV testing services through VCT 
approach. Distance between child’s residence and health facility precipitate other problems 
such as: poor adherence to treatments, lost to follow up and occurrence of recurrent 
opportunistic infections. According to the PASADA 2010 annual report on medical services, the 
centre reported that of clients who had poor adherence to ART treatment and who were lost to 
follow up, the majority constituted those who stayed relatively far from health facilities. It 
implies that children in the IPCF group would have limited access health care services.  
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Likewise, reports have shown that the number of HIV positive children who have access to HIV 
care and treatment services have remained low despite a reported improvement access among 
adults (Kellerman, 2010). In his study, Laufer (2006:623) highlighted the need for examining 
different approaches to increase access to care and treatment services in children. This is a 
clear indication for reviewing the current approaches (VCT and PICT) for identification of HIV 
positive children.  Unless alternative innovative approaches are put in place to ensure all 
children have equal chance to accessing health care services, many children will be denied 
opportunities to receive an HIV test. This research shows that, through community network 
more HIV positive children are reached thus improve access to HIV testing among children. 
Involvement of medical, non-medical personnel, community health care providers, clients, 
hospital visitors, community recognized personnel in the IPCF approach describes it as a unique 
approach compared to other traditional approaches (VCT & PICT). The traditional approaches 
for HIV test require children to show up at health facilities. Children who fail to make it to 
health facilities due to distance and financial constraints are automatically excluded from being 
picked by the traditional approaches thus missing the opportunity for an HIV test. The IPCF 
approach utilizes the unique nature of African extended families which allows individuals to 
support each other do so particularly for the children living with HIV.  Implementation of the 
IPCF intervention aligns with the WHO recommendation that; nations and programmes need to 
look for multiple accesses such as: schools, communities, friends, and peers in order to improve 
access to HIV testing services in children (WHO, 2011).  
  
4.5.  Care givers type. 
The research revealed that more children in the IPCF group (45%) compared to the VCT group 
(37%) were cared by biological parents. Authors have reported biological parents being one of 
important barriers to diagnosis and disclosure of HIV in children. A systematic review 
conducted by Lori et al (2007: 156)  assessed the patterns on disclosing HIV to children and 
reported that biological parents were reluctant to test and disclose children’s status due to fear 
of emotional consequences associated with disclosure and disclosure of secrets of family 
members. The described fear of disclosing children’s HIV status among biological parents in this 
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context may attribute to delays to diagnosing HIV in children. In the literature we see 
reluctance of biological parents to test their children due to the fear of disclosing their family 
secretes (Lori et al, 2007: 156). Our study findings contradict with the literature and show that 
biological parents welcomed any effort that enhanced diagnosis of HIV in their children. The 
research has shown that more children in the IPCF (23%) had both of their biological parents 
compared to only 16% in the VCT group. Among children in the IPCF group who were double 
orphans constituted 34% while those in the VCT group constitute 41%. These findings describe 
the ability of the IPCF intervention to override the barrier to diagnose HIV in children due to 
fears or reluctance of biological parents. This is an important finding that describes the value 
IPCF brings in the global efforts to improve access to HIV test in children. Delayed diagnosis of 
HIV in children has been associated with many poor health outcomes; therefore reluctance of 
biological parents to diagnosing their children is unconsciously done by the parents but 
presents a huge threat to the children’s health outcomes. We find this character very unique 
and we make a recommendation for future study to evaluate the superiority of the IPCF in 
counteracting the effect of biological parents in delaying diagnosis of HIV in children.   
 
4.6. Loss of biological parents 
In general many children had lost one or both of their biological parents and therefore reported 
to have lived with at least three different relatives within a range of three to five years. These 
findings were consistent in the adult and children focus group discussions.  The proportions of   
biological parents were persistently low throughout twelve rounds of adult focus group 
discussions. This finding confirm what is written in the literature that many children who are 
HIV positive are more likely to have lost one or both of their parents due to HIV and those who 
have lost both parents have tendency to shift between different care givers (Leyenaar, 
2005:259). A loss of biological parent[s] for a child has shown to mark a critical point for that 
child to start experiencing physical, social, emotional and psychological challenges that affect 
children’s wellness.  Children reported episodes of recurrent illnesses and family conflicts most 
of times started after a loss of biological parent.  
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Children aged 13 to 18 years who had lost their parents at a younger age had been unprepared 
for the loss and many portrayed their past life as being a painful experience that lasted to a 
later age.  Children who moved between different caregivers experienced more episodes of 
recurrent illness compared to children who had a permanent residence. These findings are 
similar to a previous research on the impact of HIV at a household level in Tanzania conducted 
by Urassa et al (2001:2017) which reported a 44% household mobility of family members after 
a death of the head of the household due to HIV. The consequences of shifting between care 
givers among children were not limited to interruption of continuum of medical care but also 
loss of medical records and loss of clarity on the children’s health needs amongst care givers. 
During the focus group discussions, guardians particularly non- biological parents remained 
unfamiliar of their children’s HIV status for a while until when the children were brought to 
health facility. Our interpretation to this phenomenon is that despite a high frequency to shift 
between caregivers accurate information on the children’s health is never passed on or is only 
partially shared the fact that leads to increased episodes of treatment interruptions thus 
triggers episodes of recurrent illnesses.  During focus group discussions of both children and 
guardians, features that suggested poor adherence to ARV in children with high tendency to 
shift were evident.      
4.7. Level of CD4 count 
A larger proportion of children in the IPCF group (47%) had CD4 count above 500 cells /ml 
compared to only 37% in the VCT group (Figure 3). We noted a difference in CD4 distribution 
among children in two groups as such; children in the IPCF had both low and high CD4 count 
contrary to those in the VCT group whose majority had low CD4 count. IPCF approach has 
chance to find children with high CD4 count as it gets more accepted. Currently children with 
low CD4 are also found because of being repeatedly missed by the traditional approaches. 
Previous reports have shown children are generally diagnosed at a later stage of disease 
progression where CD4 count is already very low (Wortley et al, 1995:487; Sutcliffe CG et al, 
2008: 477; Cooke et al, 2009:9; Topp, 2012: 1735). Delayed diagnosis of HIV in children has a 
direct impact on the number of children who are initiated on ART. Analysis of international 
cohort data had confirmed that low numbers of HIV infected children who are started on 
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antiretroviral therapy and those who were started were already at a very late stage of disease 
progression mainly due to a delay in HIV testing (Sutcliffe, 2008:877).   
 
Researchers study shows the ability of the IPCF approach to identify children with low CD4 
count something that allow providers to predicts those with high risk of poor prognosis. 
Children when diagnosed at high CD4 count allow a better plan of care thus high chances of 
good health outcomes. Identification of HIV positive children at an early stage of disease 
progression (high CD4 count) is a critical step for programmes and nations towards making a 
reasonable progress in achieving the millennium development goal number four - to reduce 
child mortality (WHO, 2007; UNAIDS, 2004). We therefore recommend scale up of the IPCF 
intervention to supplement other traditional approaches for identification of HIV positive 
children.   
 
4.8. Health provider visits prior to an HIV test 
The research has shown that children and their guardians had multiple visits to health care 
providers without receiving an HIV test. Strikingly, children in the IPCF as compared to those in 
the VCT groups had over 4 times likelihood of visiting more than three health care providers 
prior to an HIV test (P-Value =0.005). This difference remained significant even after accounting 
for age and sex of the children. Explanation as to why children in the IPCF group than those in 
the VCT had made more health facility visits prior to receiving an HIV test is beyond scope of 
this study. However, it the information would be very useful for programmes in order to 
improve quality of health services in HIV positive children. It is striking that health care 
providers did not consider initiation of an HIV test despite clinical features suggestive of HIV as 
a result many children were missed the opportunity to test for HIV.  The government of 
Tanzania requires VCT and provider initiated counselling and testing for HIV (PICT) to be 
implemented as a standard procedure in all levels of health facilities (NACP, 2007:3). A high 
magnitude of missed opportunities for an HIV test depicted by our study and many other 
previous studies (WHO, 2010) is a clear indication that the two traditional approaches (VCT and 
PICT) are not adequately implemented by health care providers. The IPCF approach assisted 
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PASADA to identify children from the community rather than in the health facility thus 
complement to the systems for identification of HIV positive children. They welcomed any 
initiative by health care providers that enhanced early diagnosis of HIV in children. Parents and 
guardians reported any initiative to enhance diagnosis of HIV in their children as life saving   
 
It is very important for health care providers to be more vigilant in making sound clinical 
judgments and rule out the possibility for missing children living with HIV when children make 
hospital visits. Health care providers should also keep up with training that raise their 
awareness on HIV in order to provide sufficient attention to sick children with high index 
suspicion for HIV.  
 
4.9. HIV disclosure to children 
Delayed disclosure of HIV in children was prevalent across all groups IPCF and VCT. About 70% 
of all children remained with undisclosed HIV status for over six months following a diagnosis.  
Children in the IPCF group were more likely not to have been told their status compared to 
children in the VCT group and this difference could be explained by the fact that children in the 
VCT group had stayed in the programme for a much longer time than those in the IPCF group 
thus increasing their chance for disclosure. In addition to programmatic challenges, guardians 
and biological parents accounts for delayed disclosure of HIV to children. This finding suggests 
implementation of both VCT and IPCF need to be tailored with disclosure strategies to ensure 
that desirable health outcomes for children are guaranteed. Also it is critical for programs to 
put robust measure for HIV disclosure to children disclosure especially in situation of high influx 
children identified with HIV. Authors have associated HIV disclosure to children with desirable 
and better health outcomes (Ferris, 2007: 1088, WHO, 2011 & Wortley et al, 1995: 487). 
Delayed disclosure has been reported to be one of major challenges facing guardians and 
health care providers for children living with HIV. A study conducted by Lori et al (2007: 156) 
revealed that guardians and caregivers have been reluctant to conduct disclosure fearing the 
emotional consequences of the parents and guardians and fear of ethical obligations especially 
when guardians and parents started to ask providers not to use the words HIV and AIDS   
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4.10. Age and disclosure of HIV to children 
A study conducted by Bunn in many of the African countries on the experience of children’s 
disclosure revealed  that children felt depressed and isolated if they were not given permission 
to talk openly about their health. This report indicated that guardians of HIV positive and 
cancer children were reluctant to disclose the status to their children fearing that the children 
would lose hope and die more quickly or would commit suicide (Bunn, 2010:3). In this study, 
researchers found that many children discovered their HIV status through their own initiatives 
at an age way below 16 years, the recommended age by the government of Tanzania for HIV 
disclosure to children (NACP, 2007:14).  Many children were eager to know about their health 
and particularly in relation to their attendance to routine HIV clinics. Some children while trying 
to understand from their care givers and guardians as to why they had to take medications, 
asked questions that often did not get conclusive answers. Guardians and parents were often 
reported to avoid providing truthful responses by shifting the responsibility to answer the 
questions related to disclosure to health care providers.   The fact that HIV positive children 
need truthful information about their health has been echoed by the WHO (WHO, 2011:10).  
 
We found contradictions on the appropriate age for HIV disclosure to children. Various 
guidelines have not mentioned a specific age, others have stated school going age and others 
like that of Tanzania has stated age 16 years as appropriate age for disclosure. Analysis made by 
Lori had revealed shown that there is lack of evidence on the appropriate age for HIV disclosure 
in children. We propose a study to evaluate these approaches and provide recommendation 
based on the context. We think lack of clarity in the guidelines is also a barrier for health care 
providers to instigate HIV disclosure to children. During focus group discussions we conducted, 
we found children at aged between 7 and 13 years were capable to understand the meaning of 
HIV and were able to associate the status with their wellbeing. In this regard we make a 
recommendation for the government of Tanzania to consider 13 years as age of HIV disclosure 
to children.  At age 13 the majority of children start to seek clarifications on issues related to 
their health, most of the children move from primary to secondary school the level and have a 
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much wider peer interaction. Also at this age majority of children encounter their first sexual 
debut thus clarity in their health status is critical for their own safety and for others.   
 
4.11. Access to health services 
We found a sustained increment in the number of HIV positive children identified and enrolled 
in PASADA clinics seven months after the IPCF intervention. Initiation of ARV in children 
requires series of events including: assessment of readiness of guardians, check of CD4 count, 
renal function, and liver function. This process may take longer than six months, however; the 
shorter period it takes the effective system is. It is therefore not ideal to rely on the number of 
children initiated on ARV and attribute this effect to the IPCF intervention due to the short 
study period. However, we learn that PASADA system of initiating children on ARV needs to be 
strengthened. IPCF also identified children with high CD4 count; therefore not qualify for ARV 
thus may explain the low proportion of children initiated on ARV after IPCF was implemented 
(Table 5). A study to assess long term health effects of IPCF which include its effect on 
enrolment on ARV is recommended.      
 
In spite of a documented slight increment in the percentage of HIV positive children identified 
in Tanzania between 2009 and 2010, access to health services among children living with HIV is 
still a big problem (NACP, 2011:8). Previous studies have shown that the proportion of children 
who are tested for HIV represent a very small proportion of children living with HIV (UNAIDS, 
2010; Laufer, 2006:623; Kellerman, 2010). In order to increase the number of children on ART, 
it is important for programmes to ensure that more children are tested for HIV. In this study we 
see an increment in the number of children initiated on ARV seven months after 
implementation of IPCF intervention - a finding that suggests IPCF to be an important strategy 
to increase number of children who are initiated on ARV. The government of Tanzania through 
the Tanzanian Health Sector HIV/AIDS Strategic Plan proposes that by 2012, 20% of people 
living with HIV who are taking ART should constitute children (HSHSP, 2007:8). The IPCF 
approach possesses valuable attributes that may assist the government of Tanzania to achieve 
this target.    
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4.12. HIV and witchcraft 
Beliefs that associated HIV with witchcraft prevailed in both adults’ and children’s group 
discussions. Although participants did not admit to have active involvement with witchcraft 
practices, they described people living with HIV to associate HIV and witchcraft and to seek 
consultations from traditional healers in addition to consulting with biomedical providers. 
These findings are similar to what was reported in Sudan, a study conducted to investigate 
beliefs that associate HIV/AIDS and witchcraft (Allen, 2007:356). In Tanzania and many other 
African countries, utilization of traditional healers is a common practice. Studies have shown 
that over 80 percent of people in African countries consult with traditional healer before they 
see biomedical practitioners (Unite for Site, 2013).         
 
Association of HIV with witchcraft has many implications on the health outcomes of PLHIV. 
According to the PASADA 2010 medical annual report, people with high tendency to default 
from ARV treatment had been associated with tendency to consult with either traditional 
healers or religious leaders prior to defaulting from the ARV treatments (PASADA, 2010). In 
addition, association of HIV/AIDS with witchcraft has a lot of economic and social implications. 
Many societies consider use of traditional healers as an evil or a socially unacceptable practice. 
This may explain why focus group discussion participants did not speak about having traditional 
healers. Use of traditional healers has implications and is a challenge for many PLHIV. For 
instance, cost associated with transportation, payment for services potential causes of drawing 
financial and none financial resources from families. Due to its chronic nature, HIV/AIDS itself 
can entice people living with HIV to seek solutions from traditional healers in order to obtain 
solutions of their illness. Consequently while seeking consultations from traditional healers; 
people are delaying undertaking HIV tests.  For children in particularly, where decisions rely on 
the ability of guardians or parents to take the children for medical care, the process may take a 
much longer time hence high risk of poor health outcomes. The time that is spent seeking help 
from traditional healers by people living with HIV who are already taking ARV also poses a huge 
barrier for the PLHIV  to meet the care and treatment requirements for follow up.  These 
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findings indicate that it is important for programmes that offer HIV services to integrate specific 
services that allow involvement of traditional healers to partnership with biomedical 
practitioners in offering HIV services.      
 
4.13. Legal Support 
Many barriers in accessing legal support existed among parents and guardians of HIV positive 
children. Single female parents were mostly affected. It appears that especially when a woman 
loses her partner, a lot of family conflicts emerge that can even result in violence among family 
members.  The findings from the focus group discussions revealed a high tendency of losing 
family possessions forcefully to people who were initially known to be friends or relatives to the 
family. This experience was common among female single parents. It was very had for the 
victims to defend their rights and the belongings due to lack of knowledge and funds. 
Participants lacked understanding of traditional laws of inheritance which limited the ability for 
social networks such as relatives and friends to provide appropriate support. In some cases 
participants reported to have stopped making follow up simply because of discouragement 
from relatives of a lost partner. In addition to women being the most affected people, children 
were also impacted directly by the practices. These findings are similar to the report by (Tamar, 
2011) that Tanzania lack equality in law of inheritance that has resulted to sufferings among 
widows and orphaned children. In this report, women particular have been reported to lose 
their properties, being evicted from their homes under witchcraft accusations and sometimes 
lose their children by abusive relatives.  
 
Effects of events of losing family possessions forcefully do not only affect the physical wellness 
but also the children’s emotional and spiritual wellness. Children expressed difficulties to cope 
with abrupt changes in the life style they lived when they had all parents to an ordinary or low 
living standard. Children who go through this transition with no psychological support are more 
likely to end up deprived in their mental wellness in the future.   
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4.14. Challenges of living with HIV positive children with guardians 
Stigma and discrimination were often mentioned as one of major challenges of living with HIV 
positive children. Compared to other guardians, single parents were more likely to experience 
discrimination from their surrounding networks. Denials of social and psychological support 
from family members were the key indicators findings and we interpret these as important 
indicators of stigma and discrimination. We found that household mobility of children between 
different caregivers especially after a loss of biological parent was a common practice. 
However, most of the times children had moved to their uncle or aunt as a first caregiver 
following loss of biological parents and grandparents became the last in the list. A very unique 
difference was depicted when children were cared by guardians other that biological parents 
compared to the children cared by grandparents. The latter group had a much reduced 
reported episodes of stigma and discrimination. Our analysis suggests that grandparents 
present a much better living environment for orphaned children compared to non-biological 
caregivers. Researchers attribute this unique characteristic of grandparents to the fact that 
grandparents are more attached to the grandchildren through the loss of their own children. 
We propose in future a study to assess short and long term health effects in children cared for 
by grandparents versus those who are cared by other than biological parents.  
  
Many other challenges of caring for HIV positive children were depicted these include: financial 
constraints, lack of nutritional supplements for ill children, limited time to keep up with hospital 
follow up requirements. Despite the positive attributes of the grandparents depicted by the 
study, one major challenge is on their physical abilities to meet the children’s demands due to 
their age. Many of the grandparents had physical disabilities such as blindness (secondary to 
cataracts), body weakness (secondary to stroke), back pain and lack of strength which in turn 
limited their ability to provide optimal care to their grandchildren. As a result many children 
took social responsibilities at a very young age and therefore denied the opportunity to grow 
while celebrating their childhood. For instance, those who assumed responsibilities of being 
bread winners of the households had to refrain from going to school or interrupted hospital 
scheduled appointments.  
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Traditionally children are required to attend monthly HIV clinic regardless of their clinical 
condition. Considering the above prevailing limitations, it is critical for programme managers 
and policy makers to review the requirements for children to visit their HIV clinic on monthly 
basis. Those who are stable on medication could have a longer duration between clinic visits.  
We also recommend a system shift from a provider centred to a family centred care to allow 
more members of the community to share the burden of caring HIV positive children.  
 
4.15. Discussion Summary  
The research evaluation has revealed that IPCF intervention has impact on the younger children 
through enabling early detection of HIV infection.  Through the intervention, we saw more 
children identified and were subsequently linked to care and treatment programme. 
Characteristically, majority of children in the IPCF group had higher CD4, travelled longer 
distance to the clinics, had multiple hospital visits prior to an HIV test compared to children in 
the VCT group. The research has revealed that provider initiated and counselling and testing is 
yet to be fully implemented according to the national guidelines for HIV counselling and testing 
and on the other hand the approach for voluntary and counselling for HIV has number of 
inadequacies particularly in reaching all children who are in need for an HIV test. Disclosure of 
HIV to children is still a huge problem that requires involvement of parents, guardians, children 
and health care providers.  We also learned that the majority of the children who are double 
orphans assume broader social responsibilities which hinder their ability to access various social 
services such as schools and medical care. Also stigma and discrimination prevail in the 
community and are important barriers to improve quality and access to HIV services in children.   
 
4.16. Limitation of the study 
The study could not obtain information on the number of children who were tested for HIV 
regardless of their HIV status as this data was not captured during implementation of the IPCF. 
Design of the IPCF had focused on service provision and less as a research therefore, the 
programme kept data for children who were tested HIV positive. For future developments, we 
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recommend IPCF programme to keep records of children reached by the intervention by the 
intervention to allow assessment of the effectiveness and efficiency of the intervention. Also 
this is a cross sectional study; therefore we lack information of the long term health outcomes 
of the two interventions IPCF and VCT such as: initiation of ART, TB episodes and mortality.  
However, researchers employed both qualitative and quantitative methods in obtaining and 
analysing the data and this is a major strength of the study that allowed a better understanding 
of relationships between variables we studied. The IPCF study was conducted in a single unit 
“PASADA” as there were no other facilities that implemented the IPCF intervention. PASADA 
has 10 outlet facilities placed in a varying social and environmental context. The study enrolled 
children from all ten service outlets canters to allow generalizability of the study findings. Also 
involvement of external experts during data collection and analysis phases of the research were 
used to minimize information bias from research team.                 
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CHAPTER FIVE: Conclusion and recommendations 
5.1. Conclusion: 
The study objectives was to assess the impact of the IPCF intervention on identification of HIV 
positive children, compare characteristics of children identified through IPCF and VCT 
intervention, determine the perception of the guardians on the approaches for identification of 
HIV positive children, and examine the experience of living with HIV among children living with 
HIV and guardians of HIV positive children. 
 
We found that IPCF intervention has impact on the younger children through enabling early 
detection of HIV. A sustained increase in the number of children enrolled in a PASADA care and 
treatment programme was found after initiation of the IPCF intervention, therefore the IPCF 
intervention has important values to supplement strategies to increase number of children with 
access to HIV testing and thus those who are initiated on ARV.   
 
We compared characteristics of children identified through IPCF and VCT and found that 
children in the IPCF group were much younger, visited multiple health facilities prior to an HIV 
test, and are more likely to have formal education compared to children in the VCT group.  
 
Also the majority of children in the IPCF reside at a further distance from HIV clinics compared 
to those in the VCT group thus hinder their ability to access HIV testing services. We also found 
more children in the IPCF group were cared by biological parents compared to those in the VCT 
group and that IPCF override the possibilities of biological parents to act as barriers of diagnosis 
and disclosure of HIV in children. Delayed disclosure of HIV to children was common among all 
children in the IPCF and VCT groups and it is one of major challenges of caring children living 
with HIV. Regarding CD4 count, majority of children in the IPCF had higher CD4 count while the 
majority in the VCT group had predominantly low CD4 count, indicating that children in the IPCF 
have higher chance for good health outcomes compared to those in the VCT group. No 
difference was noted between two groups on parental status, and nature of primary care 
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givers. Both groups of children had significant health improvement in their health and social 
outcomes after receiving an HIV test and starting on ART.       
  
Studying the perception of guardians on the approaches of identification of HIV positive 
children, most of the guardians welcomed any initiative that enhanced immediate HIV test for 
children. Guardians were frustrated by tendency of health care providers to delay HIV tests. We 
found distinction between IPCF and VCT approaches as such, in the IPCF, children are identified 
while they are still at the community they live and there is active involvement of families, 
communities, and health care providers. Those who tested for HIV through IPCF reported the 
approach as friendly and “lifesaving”. Many guardians and biological parents missed the 
opportunity to test their children and resulted to delayed HIV diagnosis. We learned that PICT is 
rarely practiced by health care providers according to the nation guidelines. This is of great 
concern and it indicates that there must be additional methods of sensitising HCPs to the need 
to test children for HIV.  
 
Assessing the experience of living with HIV among HIV positive children and their guardians we 
learned that stigma and discrimination due to HIV prevail at the family and community levels 
and are among major barriers to improving health outcomes of HIV positive children. Many 
children had lost one or both of their biological parents and frequencies to shift between care 
givers were high. The consequences of shifting between care givers include: interruption in the 
continuum of medical care, loss of medical records, and loss of clarity on the children’s health 
needs amongst care givers. Many physical, social, emotional, and psychological challenges of 
living with HIV positive children were evident mostly after a loss of children’s biological parents.  
 
The study found that beliefs that associated HIV with witchcraft and tendency for PLHIV to 
consult with traditional healers while consulting with biomedical practitioners was a prevalent 
practice. We found existence of barriers to accessing legal support that existed among parents 
and guardians of HIV positive children. Also children lack psychosocial supports that allow them 
to cope with the changes from a full life with both biological parents to being an orphan. Other 
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challenges of caring HIV positive children reported by guardians include: financial constraints, 
lack of nutritional supplements for ill children, and limited time to keep up with hospital visits.  
 
 
5.2. Recommendations 
 
We recommend implementation of the IPCF intervention by the Tanzanian ministry of health 
and social welfare.    
 
We recommend that HIV testing strategies include programmes for HIV disclosure to children. 
The IPCF intervention enabled systems to identify more children from the community and 
children were linked thus, scale up of the IPCF intervention is an important stride to achieving 
millennium development goal IV to reducing child mortality.   
 
Due to delayed diagnosis and missed opportunity for an HIV test, we recommend that health 
care providers become more vigilant in making sound clinical judgments and take the 
opportunity to test children when they present. Also health care providers need to keep up 
with training that raise their awareness on HIV in children in order to provide sufficient 
attention to sick children with high index suspicion for HIV.  
 
We recommend a discussion about another age for HIV disclosure to children in Tanzania. 
Currently disclosure is recommended at age 16 years. We also recommend a study to evaluate 
the significance of specifying age for HIV disclosure to children versus leaving it open for health 
care providers to decide when to disclose HIV status  is paramount.   
 
Orphaned children who were cared by grandparents had shown reduced episodes of stigma 
and discrimination at a family level compared to the children who were cared by non-
grandparents caregivers. In this regard, we propose a study to assess short and long term 
health effects among children cared for by grandparents versus those who are cared by other 
than biological parents. 
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Due to high tendency of communities to associate HIV with witchcraft and PLHIV seek 
consultation from traditional healers prior to consulting with biomedical practitioners, we 
recommend care and treatment programmes to consider a mutual collaboration with 
traditional healers in order to improve health outcomes of PLHIV. We also recommend 
programmes that offer legal and psychosocial support for families to be tailored with care and 
treatment programmes.       
 
Traditionally children living with HIV are required to attend HIV clinics on monthly basis 
regardless of their clinical condition. We recommend a system change to extend time intervals 
between clinic visits for children who are stable on ARV medications.  
 
The study revealed that the burden of caring children living with HIV is a heavy burden for 
parents and guardians especially when health systems limit active involvement of communities 
to provide optimal health care for the children. We therefore recommend a system shift from 
provider centred care to a family centred care approach to ensure the burden of caring children 
living with HIV is shared across families and communities with appropriate support. 
 
Due to lack of information on the number of children who were reached by the IPCF and tested 
for HIV, we recommend a follow up study to gather all information regardless of the children 
HIV status to allow fully assessment of the efficacy of the interventions IPCF, VCT and PICT.  
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APPENDICES  
Appendix I: Participants information sheet 
 
 
You are invited to take part in a research project to evaluate pediatrics HIV intensified case 
finding, PASADA’s approach to identifying HIV positive children in the community.  
 
I would like to thank you for your time and efforts to understand our study.  This discussion will 
take approximately 30 minutes. 
 
The information sheet summarizes the contents of the study that you may wish to take part in. 
For you to decide whether or not you agree or disagree to be part of this study, you will be 
provided with adequate time to ask questions to any of the health care providers and research 
team. Room for questions will still remain open even after this short discussion. Questions can 
be direct or by using the telephone numbers provided at the end of this sheet. 
Again I would like to thank you for your time, please take time to make your decision. 
 
i. What is the purpose of the study? 
We want to evaluate the pediatric HIV intensified case finding (PICF), a PASADA initiative to 
reduce the burden of HIV in children. 
 
ii. Is it a must for me to take part of this study? 
No, this is not a must. You may agree or disagree to be part of this study. Whatever your 
decision, YES or NO, it will not have any effect on the care you are receiving from our centers. 
On agreeing to take part in this study, you will be asked to sign a consent form to justify your 
decision. In whichever case, you are free to change your decision and withdraw at any point 
with or without giving reasons. This will not affect the care you are receiving from us. You are 
welcome to take time in making a decision by sharing this information with any of your health 
care providers, the research team, friends or family members.  
Participant’s information sheet 
Evaluation of the Paediatric HIV Intensified Case Finding (PICF), PASADA’s strategy of 
identifying HIV positive children and linking them to HIV testing services and appropriate 
medical care. 
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iii. What are the contents of this study if I become part of it? 
The section reads as follow; a member of our research team will speak to you and your child on 
the approach used to identify your child’s HIV status. The study will have two phases that 
require your participation. In phase one of the study, you and your child will separately have a 
chance of being invited to participate in a group discussion. The group will have 8 to 12 
members who will present with similar status as that of yours of caring a HIV positive child. The 
discussion will base on you and your child’s life experience that relates to the child’s health 
before and after being identified to have HIV. This phase will take 45 to 60 minutes. In phase 
two, the child will be interviewed and asked demographic and social information which is 
considered to have influence on the child’s health. Phase two is expected to take 15 to 20 
minutes. This information is prepared for you to keep as a reminder of the aim of the study.  
 
iv. Am I going to acquire any benefit from participating?  
There is no direct benefit to participants; however participants may find very useful information 
when discussing the questionnaire with care providers and during focus group discussions. 
Participants will have the opportunity to experience the way in which other people are 
managing to overcome the challenges of living with HIV. The anticipated benefit is to verify 
whether the PICF has useful elements that may reduce the burden of HIV in children and in the 
community in general.   
 
v. Are there any risks to me if I take part in the study? 
This will depend on the degree of tolerance of individual participants. Some participants may 
become emotionally upset. The research team is prepared to handle any situation of this nature 
appropriately if it happens.  
 
vi. Will my involvement in the study be kept confidential? 
Information which will be collected in this study will be kept confidential. Efforts will be made 
so that no one may identify you. Whatever information you are going to provide will be kept 
separate from your personal information (for example your name and personal address). The 
research team will use numbers or codes and not your names. There will be no access to your 
information from anyone outside the study. 
 
vii. Will I get the results of the study? 
At the end of the study, the report will be sent to the care and treatment center where you 
access your medical care. 
 
viii. Who is the main organizer of the research? 
The following are people who you can contact for any information with regards to the research:  
 
Questions about the study:  
Dr. Frank Manase, PASADA: Tel +255-754-383896 
Email-fmanase@yahoo.com 
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Any ethical questions or human right issues about the study: 
Muhimbili University of Health and Allied Sciences Ethics Committee:  
Professor Eligius Lyamuya, 
Ethics Committee Director,  
Telephone:  +255-754-495933 
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Appendix II: Consent form for children and adults (in Swahili) 
 
a. Guardián. 
1. I …………………………… (name) declare to have understood the purpose of the research and that I am 
not going to gain any financial benefit from my decisión to participate in the study.  
 
2. I had sufficient time to ask questions and that I can withdraw from the study at any time without 
any form of penalt.  
 
3. I give consent to participate in the study. 
 
Name ________________________________    
 
Signature  _____________________________   Date  ________________ 
 
Research assistant:  Signature  __________________ Date: _______________    
 
Witnes 
Health care provider or guardian 
 
Signature ______________________________  Date: _______________  
 
b. Child. 
Children assent form. 
1. I ……………………………………………..,  have understood the contents of the study and agreed 
to participate together with my guardian 
(Name)…………………………………………………………………….who is my 
……………………………………………., 
2. I do understand that I am free to agree or disagree with sharing information at any 
point of the study without affecting the privilege I have of accessing PASADA  health 
care services.  
 
3. I agree to participate in this study. 
 
i. Signature of the child………………………………………………….. 
 
ii. Researcher Name………………………………………….………. 
 
iii. Researcher signature……………………………………………… 
 
iv. Date…………………………………………………………..…… 
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Appendix III: Focus group discussion guide 
 
 
Focus group discussion guide. 
  Mark X ---PICT [    ]          Normal VCT [    ] 
 The discussion will have groups of eight to twelve children.   
 The group discussion facilitator will initiate and maintain discussion using 
the following guiding questions: 
1. How were things in your life before you came to PASADA? 
2. How did you come to hear about PASADA? 
3. How are things now that you are in the PASADA?  
4. How does being HIV-positive affect your life? 
5. What is your opinion on the approach used to identify your HIV status? 
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Appendix IV: Questionnaire  
 
Name of research assistant………………………………………………... 
Work station (Name of the facility)………………………………………. 
Registration number………………………………………………………. 
CTC Number……………………………………………………………… 
Location 
District……………………...Ward………………………………………. 
Physical address (Explain)………………………………………………………………….. 
Sex   Male [    ] Female [    ] 
Age ………………………. [Years] 
Parental status; Two parents [    ]   Single parent [   ] No parents [   ] 
If orphaned state at what age did the child lose his/her parents.  
 Father……..Years,    Mother………Years 
 
 
1. What is your level of education  
a. No formal education   [   ] 
b. Not complete primary level of education [   ] 
c. Primary education   [   ] 
d. Secondary Education          [   ] 
e. Not Complete Secondary  education [   ] 
 
2. What is the average time you spend from your home until when you reach PASADA facility 
for health care service. 
a. Less than 2 hours  [   ] 
b. 2 to 4 hours          [   ] 
c. Above 4 hours      [   ] Write number in hrs…………….. 
 
3. Describe relationship with your primary care giver. 
a. Biological parent  [    ] 
b. Aunt   [    ] 
c. Uncle   [    ] 
d. Family friend  [    ] 
e. Good Samaritan  [    ] 
f. Step parents                [    ] 
g. None of the above [   ] Explain……………………….. 
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4. At what age the child joined PASADA? ……………Years 
 
5. Name relation of the person accompanied you during your HIV test 
a. Biological parent  [    ] 
b. Aunt   [    ] 
c. Uncle   [    ] 
d. Family friend  [    ] 
e. Good Samaritan  [    ] 
f. Step parents                [    ] 
g. None of the above [    ] Explain……………………….. 
6. How many health facilities you visited seeking appropriate heath care before joining 
PASADA? 
a. None 
b. One 
c. Two 
d. Three 
e. More than three [state]…….. 
7. What approach was used to identify the child’s HIV status identified?   
a. Voluntary counseling and testing (VCT)  [    ] 
b. Provider initiated counseling and testing (PICT) [    ] 
c. Pediatric intensified case finding (IPCF)  [    ] 
8. How long did it take from testing to disclosure of child’s HIV status?  
a. Less than three months [    ] 
b. Four to six months       [    ] 
c. Over six months       [    ] Mention (Months)…………………. 
9. Was the child linked to any of the following services? 
a. HBC   [    ] 
b. Special pediatric clinic [    ] 
c. OVC services  [    ]  
d. Others   [    ] Explain……………………. 
10. Was the approach used to identify HIV status of the child associated with stigma ?  
a. No    [    ] 
b. Yes   [    ] 
If yes give explanation…………………………………………… 
(Ask question 10 and 11 at the end of interview where the child will be assessed to determine 
whether she/he needs extra help to assist sharing of this information. This can be more privacy 
or any form of help from other children).   
11. Is there a time in your life you would consider being mistreated/Abused?   
a. Yes            [    ] if yes go to number 5 and 6 
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b. No  [    ] 
12. In which way have you have been mistreated/abused? (More than one answer is 
acceptable) 
a. Physical abuse  [    ] 
b. Emotional abuse  [    ] 
c. Sexual abuse  [    ] 
d. Negligence [    ] 
e. Chose not to say  [    ] 
f. Others   [    ] Mention……………………………. 
 
 
 
To be referred to the clinical notes. 
13. What was the child’s first CD4 count (% for <6years and absolute value for >6 years. 
……………………………. 
14. What was the child’s first WHO clinical staging 
a. Stage one  [    ] 
b. Stage two  [    ] 
c. Stage three  [    ] 
d. Stage four   [    ]  
e. Not known   [    ] 
15. Is the child taking ARV? 
a. Yes    [    ] 
b. No    [    ] 
16. What was the child’s initial diagnosis for opportunistic infections    
a. Malnutrition   [    ] 
b. Tuberculosis   [    ] 
c. Skin Condition   [    ] 
d. Chest condition   [    ] 
e. Gastro intestinal condition            [    ] 
f. Others    [    ] Mention…………………. 
17. What was the initial body weight of the child when enrolled to PASADA……………..(Kg) 
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Appendix V: Permission to conduct research at PASADA institute, a research site. 
 
Dr. Frank Manase 
BOX 70255 
Dar es Salaam 
Dear Dr. Manose, 
Dar es salaam, 24th August 2010 
RE: Permission to conduct the study entitled "Evaluation of Pediatric Intensified 
Case Finding - PASADA's approach to reducing the burden of HIV in children, 
Dar es salaam Tanzania" at PASADA 
Reference is made to the above heading. 
I am hereby pleased to inform you that permission to conduct this study at PASADA's 
facility is granted. You may proceed with all other necessary arrangements. 
Yours sincerely, 
Mary Ash 
(Executive Director) 
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Appendix VI: Ethical clearance: Tanzania National Institute of Medical 
Research
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Appendix VI: Ethical approval UCT 
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Appendix VII:  IPCF identification coupon 
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Appendix VIII: Supplement figures 
Figure 5. Number of health facilities visited by children prior to an HIV test by Approach (IPCF vs 
VCT) 
 
 
Figure 6. Age at which an HIV test was performed by Approach (IPCF vs VCT) 
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Figure 7. Age of children by Approach (IPCF vs VCT) 
 
 
Figure 8. Number of children initiated on anti-retroviral treatments by period (Before Vs After) 
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